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PREFACE 
 
In October 2006, in the north of Portugal, as a result of human and economic constraints, 
the out-of-hours gastroenterology emergency was reviewed, reorganized and 
restructured, by allocating in a single endoscopy unit, gastroenterologists from eight 
hospitals of the district of Oporto. Presenting this data is the product of my five years of 
work, as responsible for the management of this out-of-hours endoscopy regional center.  
 
Over the years, as healthcare has become more complex, as quality management has 
evolved, and the organization where I work has made a strong commitment to the process 
of quality improvement and patient safety, my understanding of what managing quality 
means has growth as well. My journey began as a quality risk manager, ten years ago. I 
was not trained to ask questions, sometimes difficult questions, nor to use data to give 
answers; at that time, clinical indicators and clinical audit were, for me, a complete 
mystery. After the implementation of the quality department, for which I was responsible 
from 2006-2009, I quickly realized  that quality information, clinical and non-clinical, can 
and must be used for daily operations; that it all begins with measures which must be 
integrated into every aspect of care, so that each aspect can be evaluated, understood 
and improved. I was extremely fortunate that the hospital board believed in quality and 
contributed their time to ensuring that the institution continuously strived toward 
excellence; as well, all the professionals with whom I worked, which always 
enthusiastically engaged in new projects. 
 
As a gastroenterologist, the issues of quality and patient safety, especially in the 
emergency care setting, continued to challenge me and inspire me personally and 
professionally. On the other hand, as responsible for the coordination of this  emergency 
regional model, I asked myself: is this system fair in terms of accessibility, safety and 
costs? The answer, again, was measures.  
 
Although it seems intuitive that many efficiency strategies may lead to cost savings, some 
quality drives may lead to increased expenditure. My first clinical audit in acute upper 
gastrointestinal bleeding, demonstrated that a systematic critical analysis at all levels of 
patient's care was needed. This has raised some crucial questions in my mind which I 
tried to answer in my research. 
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I wrote this thesis to fill what I perceived as a critical gap in healthcare services; to 
understand the value of data and use them in the whole process of care, as the basis for 
delivering quality care and try to overcome the economic constraints.  
 
It has been an outstanding and extremely rewarding journey. 
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SUMMARY 
 
Measurement of quality is an important area of the healthcare system. But we have to 
improve the way we look at quality within organizations and to invest in understanding the 
information across services. This perspective is essential if new models of care are 
implemented and intend to be successful. In northern Portugal, an out-of-hours 
endoscopy regional centre was set up in one tertiary trust in Oporto, o Centro Hospitalar 
do Porto. 
Overall, the research discussed in this thesis explored the aspects of non-variceal acute 
upper gastrointestinal bleeding management in the real-life context of this regionalized 
emergency healthcare model. During a 3 year period (January 2010 to December 2012), 
data from consecutive outpatients (n=332) with non-variceal acute upper gastrointestinal 
bleeding, admitted or transferred, were prospectively collected, analyzed and compared. 
The results illustrate the model's effectiveness and the challenges in understanding and 
managing the all process of care, necessary for providing high-quality care. Median time 
to out-of-hours endoscopy was 6h for direct admissions and 7.7h for transferred patients; 
90% of the procedures were performed in less than 24h. Rebleeding, 30 day mortality and 
need for surgery were respectively 9.8%, 7.4% and 6.6% and were not significantly 
different between the two groups. Age, malignancy and an admission Rockall risk score 
were predictors of in-hospital mortality, whatever the admission status. In the transferred 
group, patients with 80 years old or more showed a 11-fold significantly increased risk of 
rebleeding, than younger patients. Patients transferred with malignancy, a high risk clinical 
Rockall score and more than 80 years old presented a probability of 30-day mortality,  
three, six and sixteen times greater. The results emphasize the importance of supporting 
healthcare providers with tools that enable them to decide in their daily practice whether to 
comply with standard of care and simultaneously respond to economic constraints. 
This regionalization model has overcome the problem of emergency provision and 
demonstrated equity, safety, efficacy, effectiveness and  availability of appropriately 
trained and experienced endoscopy staff.  
We believe this may fit in a larger opportunity to improve processes and outcomes in 
acute upper gastrointestinal bleeding and other clinical contexts or regions. Nevertheless, 
it is important to determine, in the near future, the impact of regionalization in the 
economics of hospitals within the system. 
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RESUMO 
 
Actualmente é exigido um esforço constante de melhoria contínua da qualidade às 
organizações de saúde. Mas temos, cada vez mais, de avaliar a qualidade dentro das 
organizações, melhorando a informação e a comunicação. Esta perspectiva é essencial 
para que novos modelos de gestão sejam implementados e bem sucedidos. No norte de 
Portugal, foi criada uma urgência regional noturna de gastrenterologia, no Centro 
Hospitalar do Porto. 
No geral, esta dissertação analisa os cuidados prestados aos doentes no contexto das 
várias dimensões da qualidade. Este trabalho estuda e discute, comparativamente, os 
resultados obtidos em doentes admitidos diretamente nesta urgência regional com os de 
doentes transferidos de outros hospitais que se apresentaram com hemorragia digestiva 
alta não-varicosa (n = 332). Durante um período de três anos (janeiro de 2010 a 
dezembro de 2012), foram prospetivamente registados os dados destes doentes. 
O tempo mediano para a realização de endoscopia foi de 6h para as admissões diretas e 
de 7,7h para os doentes transferidos e 90% dos procedimentos foram realizados nas 
primeiras 24 horas. A recidiva hemorrágica, a mortalidade e a necessidade de cirurgia 
urgente foram respetivamente de 9,8%, 7,4% e 6,6% e semelhantes nos dois grupos. A 
idade, a malignidade e o score clínico de Rockall foram preditores de mortalidade 
hospitalar, independentemente do tipo de admissão. No grupo dos doentes transferidos, 
os que tinham uma idade igual ou superior a 80 anos apresentaram um risco 11 vezes 
superior. Os doentes com neoplasia, os portadores de um elevado score de admissão de 
Rockall e os com mais de 80 anos tinham probabilidade de mortalidade aos 30 dias, três, 
seis e dezasseis vezes maior. Os resultados enfatizam a necessidade de integração de 
metodologias e ferramentas da gestão da qualidade na área da saúde, numa perspectiva 
operacional, capaz de permitir, não só a optimização dos processos mas, 
simultaneamente, uma gestão mais eficaz dos recursos. 
Este modelo de regionalização resolveu o problema da provisão de recursos humanos e 
demonstrou equidade, segurança e eficiência, com a disponibilidade de uma equipa de 
endoscopia experiente.  
Esta tese, focalizada em aspectos nucleares da gestão da qualidade, alerta para o 
benefício de uma abordagem integrada de gestão da qualidade na saúde, neste e 
noutros contextos clínicos ou noutras regiões do País. No entanto, é importante 
determinar, num futuro próximo, o impacto económico da regionalização nas instituições 
que integram o modelo. 
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I. INTRODUCTION 
 
Ia. Context 
 
Why is this research important? 
 
Improving the quality of services is now a key requirement within any health institution. It 
is about making healthcare safer, effective, patient centered, timely, efficient and 
equitable. In the past decade, there has been a great focus on improving the quality of 
health services, but the boards are being challenged to respond to the rigor imposed by 
economic constraints.  
 
Furthermore, acute upper gastrointestinal bleeding (AUGIB) is one of the most common 
emergency medical admissions for gastroenterology and has a significant inpatient 
mortality of 10% that has not improved over the last two decades (van Leerdam, Vreeburg 
et al. 2003; Targownik and Nabalamba 2006; Lanas, Garcia-Rodriguez et al. 2009).  
 
With our ageing population, comes a number of health challenges in this area (Yachimski 
and Friedman 2008). Although the overall incidence of AUGIB seems to have declined 
since the 1990s, the studies suggest that people aged more than 60 years constitute an 
increasing proportion of those presenting with AUGIB (Thomopoulos, Vagenas et al. 
2004; Targownik and Nabalamba 2006; Lanas, Garcia-Rodriguez et al. 2009). Also, 
advanced age has been consistently identified as a risk factor for mortality in patients with 
AUGIB, in whom the outcome is influenced also by the presence of medical comorbidities, 
increased prescriptions for these comorbidities and interactions between the two (Cappell 
and Nadler 1995; Rockall, Logan et al. 1995; Hasselgren, Blomqvist et al. 1998; 
Hasselgren, Carlsson et al. 1998; Yamaguchi, Yamato et al. 2003; Baradarian, 
Ramdhaney et al. 2004; Thomopoulos, Vagenas et al. 2004). This calls for a timeliness 
and coordinated approach from diagnosis to treatment, in order to optimize favorable 
outcomes. 
 
Endoscopy in AUGIB is a time-critical procedure that should be performed in the first 24h 
(Barkun 2010). The implementation of early discharge policies is an important issue in 
today´s health care, but, in these cases, necessitates a rapid diagnostic endoscopic 
service. So, if this procedure is performed early, may avoid expensive and unnecessary 
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Figure 1: Out-of-hours endoscopy is under crisis
This Ishikawa diagram intends to give a visualization of the potential causes of a 
problem called out-of-hours endoscopy.
inpatient treatment with early discharge and reduction of the length of stay. However, how 
urgently endoscopy needs to be done is still debated (Pedroto, Dinis-Ribeiro et al. 2012). 
 
What is lacking in the current knowledge 
 
Some studies have identified serious gaps within the hospital like inadequate out-of hours-
service, inappropriate triage and staff shortages in the management of AUGIB (da 
Silveira, Lam et al. 2006; Hearnshaw, Logan et al. 2010; Jairath, Kahan et al. 2012). But 
outside factors affecting the hospital must also be taken into account: inadequate access 
of the general population to specialists; delayed ambulance service; the all structure of the 
delivery system (da Silveira, Lam et al. 2006). The diagram bellow clarifies the factors 
discriminated in the studies mentioned above, and draws attention for the need of a 
systemic approach (figure 1). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
So far as we know, there is no information available on the clinical management of AUGIB 
in relation to the current organization of the emergency health care services in Portugal, 
namely non-variceal acute upper gastrointestinal bleeding (NVAUGIB), neither a single 
cause and effect scenario to address timely endoscopy in northern Portugal. And, 
moreover, there is not a great deal of scientific analysis on these issues.  
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Paper I and II assess this two issues, from the endoscopy perspective to the 
organizational level, which can be read at the end of this chapter. 
 
Context of the innovation 
 
AUGIB is a time-critical event, the care of which should be timely, patient-focused and 
consultant-based; a 24-hours-a-day, 7-days-a week, has the essential requirements for an 
emergency model of care and the service should be organized around the patient‘s 
needs. New models of care should be beneficial to patients and staff, rather than just 
being considered for purely economic or administrative reasons. But, unlike other clinical 
areas, cardiac or stroke care, the field of emergency care in gastrointestinal emergencies, 
currently lacks a uniform set of metrics which informs providers, administrators, and 
consumers about the status of their care. All of this calls for a coordinated approach and 
organizational (national, regional or local) models of care. These must become the driving 
force for organizing, evaluating, and facilitating medical care across the full care cycle. We 
found no studies directly addressing the causal relationship between all three variables of 
care: structure, processes and outcomes, although in some, associations between 
outcomes and resources could be inferred. Our review suggested that more research is 
needed to establish a robust and effective model of gastroenterology emergency service 
delivery (Pedroto, Amaro et al. 2013). 
 
In northern Portugal, none of the institutions had sufficient resources to ensure a 24-hour 
gastroenterology emergency service. In October 2006, an out-of-hours endoscopy 
regional center was set up (Regional Gastroenterology Emergency-URGE) in one tertiary 
trust in Oporto covering a population of three million. This is the place where 30 consultant 
gastroenterologists from eight hospitals and eight nurses from the endoscopy unit are 
integrated as the gastroenterology emergency team, everyday from 8pm to 8am; they are 
responsible for handling gastroenterology emergencies, especially those requiring urgent 
endoscopy. 
 
Although ppopulation-base epidemiology data are important to get insight in the actual 
healthcare problem, it is vital to understand the current demand, outcomes and causes of 
NVAUGIB to inform and improve future management of this organizational acute model of 
care in northern Portugal. 
 
In northern Portugal, the management of NVAUGIB in the past decade was dependent on 
the organizational structure of each hospital. Until October 2006, endoscopy was 
/ Chapter I - Introduction 
 
32 
performed within normal working hours only, i.e. usually the next working day after 
admission. The establishment of a dedicated out-of-hours endoscopy unit gave us the 
opportunity and clinical material to inquire whether the new model of treatment covers the 
various dimensions of quality in health care. 
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I. INTRODUCTION 
 
Ib. Outline and Aims of the Thesis 
 
AUGIB is defined as acute bleeding into the lumen of the gastrointestinal tract above the 
ligament of Trietz, typically presenting with haematemesis or melaena. It is the 
commonest emergency medical admission for gastroenterology, has an overall 30 day 
case mortality in the range of 2-14%, and is associated with a significant burden on health 
care resources. AUGIB is commonly categorized as variceal [from oesophageal or gastric 
varices] or non variceal bleeding. Non variceal bleeding is more common and can be 
further subdivided by its causes, being the peptic ulcer the most common. 
 
Quality in the health care (chapter IV) setting may be defined as the extent to which a 
health care service produces a desired outcome. Quality improvement (QI) is now a 
driving force in health care and is an essential aspect of service delivery at all levels. But, 
unless we measure, it‘s difficult to know exactly where we stand, what to improve and 
whether we have in fact achieved improvement; so, efforts to improve systems or 
processes must be driven by reliable data.  
 
This thesis investigates, by covering the all process of care, the outcomes of NVAUGIB 
and the underlying causes and consequences, in the setting of a new regional emergency 
organizational model by assuming a systems perspective. We thought that this model 
might offer high availability and quality of care at every stage, as well as continuity 
between each step of an interconnected treatment process, that would reduce the 
patient‘s waiting time for endoscopy, speed up recovery with a multi-disciplinary approach,  
and manage resources in a more efficient way. 
 
The purpose of the research substantiated in this thesis was to increase the 
understanding of NVAUGIB in the northern Portugal and the quality of the regional 
healthcare managing process, by implementing a prospective collection of data and 
outcome. 
 
To fulfill the purpose of the thesis, four research questions have been posed in the context 
of the regional model of care. The formulation of the questions was governed by the 
relevance to understanding and managing NVAUGIB and the potential for healthcare QI. 
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Research Questions 
 
 
 
Research Question 1 
 
The care provided in NVAUGIB was accessible  
and timely? 
 
 
 
 
Research Question 2 
 
The care provided in NVAUGIB was appropriate 
 and effective? 
 
 
 
 
Research Question 3 
 
The care provided in NVAUGIB was supported by best evidence  
and practice guidelines? 
 
 
 
 
Research Question 4 
 
The care provided in NVAUGIB was safe and efficient? 
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I. INTRODUCTION 
 
Ic.Thesis Structure 
 
This thesis is divided into six chapters. 
 
The first chapter starts with a description of the selected research area followed by the 
purpose and the research questions. These issues fall within the substance of papers I 
and II, the controversies around endoscopy time frame and a review of emergency 
models of care in emergency gastroenterology. The thesis structure is presented. 
The chapter two is a presentation of the literature review, namely in the management of 
healthcare quality. Clarifications of the key concepts and previous studies in non-variceal 
acute upper gastrointestinal bleeding, in order to get a deeper insight of the subject matter 
can be find in this chapter. 
 
The chapter three explains the methodology and describes the techniques used in the 
collection and analysis of data. 
 
The chapter that follows contains an analysis of the empirical data followed by its 
presentation in paper III. 
 
Chapter five discusses whether the aims and objectives of the study were achieved.  
 
A summary and conclusions of the research will be presented, as well as some 
recommendations for management and future research, in chapter six. 
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II. BACKGROUND 
 
IIa. Quality in Health Care 
 
IIa1. Definition and Dimensions of Quality 
 
Over time, quality has been defined in several ways. Within healthcare, there is no 
universally accepted definition of quality. Quality of care encompasses many definitions, 
dependent on the author or institute defining the term, or if they are used in relation to 
health care or health care systems. For instance, the Portuguese National Health Service 
represents a universal care system run by the government's Department of Health in a 
structured and uniform manner. But, but for example, The United States' health care 
system, is operated by several different entities, including the government, managed care 
organizations, and insurance companies. Donabedian, the leading figure in the theory and 
management of quality of care, had already suggested that quality will always differ from 
person to person, largely dependent on ―where we are located in the system of care and 
on what the nature and extent of our responsibilities are‖ (Donabedian 1988).  
Every healthcare organization provides a different level of quality, with higher levels of 
quality always correlating with the experience of those providing the care (HS 1990). High 
quality standards do rely heavily on a well-organized system, with real improvement in 
quality dependent on continuous improvement throughout the organization, through 
constant effort to reduce waste, rework, and complexity (Berwick 1989). The more 
efficient and content the work environment is, the higher the quality of care experienced 
by the patient. 
 
At the present, I believe that for most of our health care professionals, the definitions of 
quality rely just on the technical excellence with which care is provided and the 
characteristics of interactions between provider and patient, as stated by Blumenthal 
(Blumenthal 1996). 
 
In 1980, Donabedian defined care of high quality as ―that kind of care which is expected to 
maximize and inclusive measure the patient welfare, after one has taken account of the 
balance of expected gains and losses that attend the process of care in all its parts" 
(Donabedian 1980). In 1984, the American Medical Association defined high-quality care 
as care ―which consistently contributes to the improvement or maintenance of quality 
and/or duration of life"(1986). The association identified specific attributes of care that 
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Figure 2: The quality dimensions proposed by the Institute of Medicine
should be examined in determining its quality, including an emphasis on health promotion 
and disease prevention, timeliness, the informed participation of patients, attention to the 
scientific basis of medicine, and the efficient use of resources. One of the most cited 
definitions, was formulated by the Institute of Medicine (IOM) in 1990, and defined quality 
as the ―degree to which health services for individuals and populations increase the 
likelihood of desired health outcomes and are consistent with current professional 
knowledge" (Lohr KN 1992). And in fact, the US health care system has been at the 
forefront of health care QI efforts for over a century. Dr. Ernest Amory Codman (1869–
1940), a physician at the Massachusetts General Hospital in Boston, was among the first 
in the developed world to highlight the problem of poor quality in health care. He 
subsequently set a standard for open, honest, and public evaluation of the end results of 
medical and hospital care (Neuhauser 1990). Since then, much work has been done in 
the USA by governmental agencies such as the Joint Commission on Accreditation of 
Healthcare Organizations and the Agency for Healthcare Quality and Research, and 
various professional societies. However, fourteen years ago, two reports from the IOM 
suggested that there was a long way to go before Americans could enjoy safe and 
clinically effective service (Institute of Medicine 1999; Medicine 2001). The first report, To 
Err is Human estimated that nearly 44,000 Americans died each year as a result of 
medical errors. More people died in a given year as a result of medical errors than from 
motor vehicle accidents, breast cancer, or AIDS. Total national costs of preventable 
adverse events were estimated to be between $ 17 billion and $29 billion. The second 
IOM report Crossing the Quality Chasm, asked for a fundamental change, recommending 
that the delivery of health care in the 21st century should be based on 6 key dimensions: 
1) safety—avoid injury to patients from the care that is intended to help them; 2) 
timeliness—reduce waits and harmful 
delays; 3) effectiveness—provide services 
based on scientific knowledge to all who 
could benefit and refrain from providing 
services to those not likely to benefit 
[avoiding overuse and underuse, 
respectively]; 4) efficiency—avoid waste; 
5) equitability—provide care that does not 
vary in quality because of personal 
characteristics such as gender, ethnicity, geographical location, and socioeconomic 
status; 6) patient centeredness—provide care that is respectful of and responsive to 
individual patient preferences, needs, and values. Other countries have faced similar 
challenges. The Britain's National Health Service (NHS), as constituted in 1948, was a 
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universal system, funded predominantly by taxation, that made health care available to 
the whole population and had a strong focus on health care QI, especially since the early 
1990s. At that time, emphasis was placed on improving standards of care, and all 
professionals were mandated to scrutinize their practices through clinical audit. Clinical 
audit required professionals to look systematically at the procedures used for diagnosis, 
care, and treatment; to examine how associated resources were being used; and to 
investigate the effect care had on the outcome and quality of life for the patient. Various 
national and regional initiatives were launched to support these efforts and many 
organizations involved.  
 
I think that one of the best definitions of quality belongs to Harteloh (Harteloh 2003):  
―Quality is an optimal balance between possibilities realized and a framework of norms 
and values.‖ This conceptual definition reflects the fact that quality is an abstraction and 
does not exist as a discrete entity. Rather it is constructed based on an interaction among 
relevant actors who agree about standards (the norms and values) and components (the 
possibilities). This is in accordance with Davila's abstract definition "For many, quality 
health care is like beauty or pornography—they know it when they see it but they just can‘t 
define it" and " Ultimately, the answer to the question ―Should it be done?‖ rather than 
―Can it be done?‖ will determine what quality health care is and is not" (Davila 2002; 
Davila 2002)). 
 
The Portuguese National Health Plan for 2012-2016 defines quality in health as "... the 
provision of affordable and equitable healthcare, with an excellent professional level, 
taking into account the available resources, while achieving the citizen's adhesion and 
satisfaction. It also implies the adequacy of healthcare to the needs and expectations of 
citizens and the best possible performance".  
 
In summary, there are many different definitions of quality in health care. The 
characteristics emphasized vary according to the perspectives of the people and the 
organizations offering them. What is common to all definitions is the need to see quality of 
care as much more than just a matter of technical skills and the supply of services. Good 
quality of care must also respect the perspectives and needs of the patient and meet 
standards in ways that are safe, effective, patient-centered, timely, efficient and equitable. 
  
Regardless of what definition of quality of health care is used, it must be kept in mind that 
every system, every process and every patient are different. Those who work in health 
care need to find ways to make QI an integral component of everyone‘s work. This means 
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investments in people, technology, and processes. Most importantly, it means the support 
of our leaders and their commitment. In spite of this difficulty in defining the concept, there 
has always been the need to measure and improve quality in health care. 
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II. BACKGROUND 
 
IIa2. Quality Assessment and Improvement 
 
IIa2.1. The History of Quality Improvement 
 
There is no single definition of QI, and no approach appears to be more successful than 
another. However, there are a number of definitions that describe QI as a systematic 
approach that uses specific techniques to improve quality. The most important ingredient 
in successful and sustained improvement is the way in which the change is introduced 
and implemented. The key elements are the combination of a change (improvement) with 
a method (an approach or specific tools) to achieve a better outcome. 
 
Understanding the basics of quality is important to our ability to improve it. Thus, this 
section briefly examines the main concerns that led to the pursuit of quality in industry. 
 
During the early days of manufacturing, an operative‘s work was inspected and a decision 
made whether to accept or reject it. As businesses became larger, so did this role, and full 
time inspection jobs were created. Later on, these changes led to the birth of the separate 
inspection department with a ―chief inspector‖, reporting to either the person in charge of 
manufacturing or the works manager. With the creation of this new department, there 
came new services and issues, standards, training, recording of data and the accuracy of 
measuring equipment; the need to address defect prevention emerged. Hence the quality 
control department evolved, in charge of which was a ―quality control manager‖, with 
responsibility for the inspection services and quality control engineering.  
 
The beginning of the 20th century marked the inclusion of ―processes‖ in quality practices. 
A ―process‖ is defined as a group of activities that takes an input, adds value to it and 
provides an output, such as when a chef transforms a pile of ingredients into a meal. 
Walter Shewhart, a statistician, began to focus on controlling processes in the mid–1920s, 
making quality relevant not only for the finished product but for the processes that created 
it. Shewhart recognized that industrial processes yield data and that this data could be 
analyzed using statistical techniques to see whether a process is stable and in control, or 
if it is being affected by special causes that should be fixed. They differ from product 
orientation in that they make quality relevant, not only for the finished product, but also, for 
the process that created it. At that time, Japan‘s industrial system was virtually destroyed, 
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and it had a reputation for cheap imitation products. The Japanese recognized these 
problems and set about solving them with the help of some notable quality gurus like, 
Juran, Deming and Feigenbaum. In the early 1950‘s, quality management practices 
developed rapidly in Japan, and become a major theme in Japanese management 
philosophy, such that, by 1960, quality control and management had become a national 
issue. By the late 1960‘s/early 1970‘s Japan‘s imports into the USA and Europe increased 
significantly, due to its cheaper, higher quality products, compared to the Western 
counterparts. 
 
In 1969 the first international conference on quality control, sponsored by Japan, America 
and Europe, was held in Tokyo. In a paper given by Feigenbaum, the term ―total quality‖ 
was used for the first time, and referred to wider issues such as planning, organization 
and management responsibility. Ishikawa gave a paper explaining how ―total quality 
control‖ in Japan was different, it meaning ―company wide quality control‖, and describing 
how all employees, from top management to the workers, must study and participate in 
quality control. The quality revolution in the West was slow to follow, and did not begin 
until the early 1980‘s, when companies introduced their own quality programs and 
initiatives to counter the Japanese success (UK Governement 2005; ASQ 2011).  
 
A guru, by definition, is a good person, a wise person and a teacher. A quality guru should 
be all of these, plus have a concept and approach to quality within business that has 
made a major and lasting impact. Some examples of quality gurus are (table 1):  
 
Table 1: The gurus and their approach to quality improvement. 
 Leader Approach 
W Edwards Deming Plan, Do, Check, Act (PDCA) cycle 
Joseph M Juran Quality Trilogy 
Armand V Feigenbaum Total Quality Control 
Kaoru Ishikawa Seven basic Tools of Quality Techniques 
such as his cause and effect "fishbone" tool. 
 
W Edwards Deming placed great importance and responsibility on management, at both 
the individual and company level, believing management to be responsible for 94% of 
quality problems. He introduced a new complete philosophy of management, statistical 
evidence that quality is built and the responsibility is to change from numbers to quality. 
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Deming also encouraged a 
systematic approach to problem 
solving and promoted the widely 
known Plan, Do, Check, Act 
(PDCA) cycle (figure 3). The 
PDCA cycle is also known as the 
Deming cycle, although it was 
developed by a colleague of 
Deming, Dr Shewhart. The cycle 
is about learning and ongoing 
improvement, learning what 
works and what does not in a systematic way; and the cycle repeats; after one cycle is 
complete, another is started. 
 
Joseph M Juran developed the quality trilogy – quality planning, quality control and QI. 
Good quality management requires quality actions to be planned out, improved and 
controlled. Juran emphasized the necessity for ongoing QI through a succession of small 
improvement projects carried out throughout the organization. His ten steps to QI are: 
build awareness of the need and opportunity for improvement; set goals for improvement; 
organize to reach the goals; provide training; carry out projects to solve problems; report 
progress; give recognition; communicate results; keep score of improvements achieved 
and maintain. Each person along the chain, from product designer to final user, is a 
supplier and a customer. In addition, the person will be a process, carrying out some 
transformation or activity. 
 
Armand V Feigenbaum was the originator of ―total quality control‖, often referred to as 
total quality and defined as ―an effective system for integrating quality development, 
quality maintenance and QI efforts of the various groups within an organization, so as to 
enable production and service at the most economical levels that allow full customer 
satisfaction‖. He proposed three steps to quality: quality leadership; modern quality 
technology and organizational commitment. 
 
Kaoru Ishikawa made many contributions to quality, the most noteworthy being his 
emphasis on the human side of quality, the Ishikawa diagram and the assembly and use 
of the ―seven basic tools of quality‖, as detailed in table 2: 
 
 
Figure 3: The Deming cycle: Plan, Do, Check, Act, a 
systematic approach to problem solving.
Adapted from the Department of Trade and Industry
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All these Gurus‘ concepts can apply to healthcare. The healthcare system itself is 
unbelievably complicated and costs have raised increasingly. Patients are demanding 
more and better care. Errors are widespread. Our population is aging. At times, the 
problems seem unsolvable. 
 
The pursuit of healthcare quality came out of a concern for better health or lost lives as 
perceived by individual professionals, as Florence Nightingale. Florence Nightingale was 
a pioneer developer of survey instruments and in the graphical presentation of data. At a 
time when research reports were only beginning to include tables, Nightingale was using 
bar and pie charts, which were color coded to highlight key points [as high mortality rates 
under certain conditions] (Nightingale 1988). In recent years however, it is evident that the 
primary concern for quality comes from a pressing need to satisfy the customer (or 
patient) both in industry and healthcare. This has become the prerequisite for staying in 
business and most of the experts (Deming, Juran, Feigenbaum) in the field of quality have 
argued that focusing on quality is more beneficial than focusing on profit and consider top 
management involvement as vital. 
 
Quality now, represents a system of methodologies and practices, common to healthcare 
and industry, and an ongoing commitment to excellence that encompasses all issues and 
engages all individuals within an organization.  
 
Although the concept of quality management and its control in healthcare is not as 
advanced as it is in industry, this may be explained by the difference in the fundamental 
Table 2: The seven basic tools of quality 
 
 
Pareto analysis which are the big problems? 
Cause and effect diagrams what causes the problems? 
Stratification how is the data made up? 
Check sheets how often it occurs or is done? 
Histograms what do overall variations look like? 
Scatter charts what are the relationships between factors? 
Process control charts which variations to control and how? 
 
/ Chapter II - Background 
 
67 
concern for quality and the nature of industrial and healthcare processes. On the other 
hand, quality approaches observed in health care have been in a more reactive form. 
 
IIa2.2.  Assessing and Measuring Quality in Healthcare 
 
In 1996, the NEJM, started to publish a series of short series on the quality of medical 
care. The purpose of these series was to review the major technical concepts and issues 
that were pertinent to current discussions about the quality of care, to place those 
discussions in a political and social context, and to provide some guidance on how 
changes in techniques for measuring and improving quality could affect doctors and 
patients over the next decade (Blumenthal and Epstein 1992; Blumenthal 1996; 
Blumenthal 1996; Blumenthal and Epstein 1996).  
 
Since 1997, the emphasis on quality has increased (Health 1998). The concept of clinical 
governance has been introduced, and all NHS organizations were required to ensure 
robust arrangements for it. Unlike clinical audit, which was a professional-only activity, 
clinical governance requires professionals to work with managers. Clinical governance is 
―a framework through which NHS organizations are accountable for continuously 
improving the quality of their services and safeguarding high standards of care by creating 
an environment in which excellence in clinical care will flourish.‖ But there were still 
reasons to keep worried about health care quality, as summarized briefly by Rajan 
Madhok in 2002 (Madhok 2002). Although it is worth noting that the subject is quite 
complex, his analysis identified a number of contributory causes. First, the NHS was 
overloaded with policy matters and constant outpouring of national guidance. There was 
an unprecedented amount of policy material in the NHS relating not just to QI but also to 
other aspects of the service. Second, alongside the policy avalanche, there have been 
structural adjustments. These structural changes raised uncertainty and anxiety, leading 
to staff turnover and loss of continuity of work. Specific to the quality agenda were a 
number of national organizations with overlapping missions and hence confused 
responsibilities. Third, although there was acceptance of a commitment to creating a 
supportive and no punitive environment, some doctors and their leaders were afraid of a 
blame culture. Fourth, integrating QI efforts into mainstream work was difficult, because of 
the lack of robust information systems. Fifth, QI efforts were being led by experts and the 
practitioner left apart. Sixth, QI is a long-term program and the sense of urgency 
demonstrated by the media and the government has influenced the way in which events 
have turned out. Seventh, current arrangements for QI were not patient-centered. QI 
arrangements were organization specific and as such merely pass the responsibility from 
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one organization to another, compromising the patient's journey. He concluded that 
change management in the NHS was not well understood and practiced. From this we 
realize that all the issues mentioned are of key importance for the implementation of any 
QI initiative. But, what emerges from these lessons is that it is difficult to move from theory 
to practice, without a strong commitment to organizational culture along with the 
engagement and empowerment of all professionals. 
 
Managing organizational culture is increasingly viewed as an essential part of health 
system reform based on the premise that a major cultural transformation of the 
organization must be secured alongside structural and procedural change to deliver 
desired improvements in quality and performance. In fact, the culture of an organization is 
a key consideration in the design and implementation of QI initiatives. For example, health 
care cultures that emphasize group affiliation, teamwork, and coordination have been 
associated with greater implementation of continuous QI practices and higher functional 
health status in coronary artery bypass graft patients (Shortell, O'Brien et al. 1995; 
Shortell, Jones et al. 2000). By contrast, organizational cultures that emphasize formal 
structures, regulations and reporting relationships, appear to be negatively associated 
with QI activity (Ferlie and Shortell 2001).  
 
An essential feature of organizational culture in health care institutions will be one that 
creates accountability for QI at all levels, from top-level management to individual 
caregivers. Another important element will be optimizing communication and social 
networking in an effort to break down hierarchies and divisions that limit information 
sharing. Clinical care is ultimately delivered to patients along relatively autonomous 
service lines (i.e. gastroenterology services, surgery services, oncology services), and 
strategies need to be developed to achieve synergy among them. In other words, a 
corporate culture which can be defined as 'the deeper level of basic values, assumptions 
and beliefs, that are shared by members of an organization (Johnson G 1984). Culture 
has a powerful effect on an organization and is recognized by many as the 'glue' that 
holds an organization together and allows it to adapt to changing environments.  
 
In 2006, The World Health Organization (WHO), following this pattern of organizational 
commitment, published "Quality of care: a process for making strategic choices in health 
systems" and suggested that a health system should seek to make improvements in six 
areas or dimensions of quality, which are named and described below. These dimensions 
require that health care should be: 
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 Effective: delivering health care that is adherent to an evidence base and results in 
improved health outcomes for individuals and communities, based on need; 
 Efficient: delivering health care in a manner which maximizes resource use and 
avoids waste; 
 Accessible: delivering health care that is timely, geographically reasonable, and 
provided in a setting where skills and resources are appropriate to medical need; 
 Acceptable/patient-centered: delivering health care which takes into account the 
preferences and aspirations of individual service users and the cultures of their 
communities; 
 Equitable: delivering health care which does not vary in quality because of 
personal characteristics such as gender, race, ethnicity, geographical location, or 
socioeconomic status;  
 Safe: delivering health care which minimizes risks and harm to service users.  
One important concern of this document was to support the role of policy and strategy 
development and to be able to differentiate quality roles and responsibilities in the various 
parts of a system. They identified six domains which are interrelated and intended to help 
policy-makers to address quality issues at a more strategic level. They emphasized that 
the challenge to health systems is to ensure that engagement with patients and the 
population is at the heart of all policies and strategies for QI.  
In a period of economic constraints and healthcare reforms, people demand greater 
quality in the health care they receive and accountability in the health care system. 
Evidence for the need to improve quality is widespread. Although difficult to quantify with 
accuracy, there is clear evidence that gaps exist between what is known to be effective 
and is, from the best available evidence and research, and what happens in practice.  
 
Multiple reports indicate that variation in clinical practice is common even where agreed 
clinical practice guidelines exist. Wide, unwarranted variations that cannot be explained by 
illness severity or patient factors are frequent (Davis and Taylor-Vaisey 1997; Wennberg 
2002; Buchan 2004; Buchan, Sewell et al. 2004; Grol and Buchan 2006; Evensen, 
Sanson-Fisher et al. 2010). Studies report high rates of inappropriate care and error 
during care-giving (Institute of Medicine 1999; Medicine 2001). And variability may be 
particular relevant in the emergency setting; the work of specialists is extremely varied 
because it is based not only on the available resources that can be supplied but also on 
the nature of unpredictable demand. The structure and organization of the department, 
the technology and the professional‘s level of uncertainty go head to head with a series of 
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variables (morbidity, socioeconomic conditions and level of education, age, sex) during a 
process that lasts for a short amount of time and that requires urgent attention. 
 
Different perspectives on quality will logically call for different approaches in its 
measurement and management. Thus, a special attention must be paid to how to improve 
the quality of care to everyone, in our everyday practice. Unfortunately, the current QI 
literature predominately focuses on case reports that describe projects in a single setting 
and do not provide the in-depth project evaluation necessary to fully understand QI in 
health care. Even systematic reviews of QI have a hard time reaching definitive 
conclusions as they generally conclude project evaluations and cannot establish whether 
improvements in quality occur, if improvements were present and whether those 
improvements were even causally related to the QI effort (Vest and Gamm 2009; 
Dellifraine, Langabeer et al. 2010). Also, the literature has identified: a lack of 
documentation about how major illnesses are treated in most health care systems; a lack 
of systematic outcome assessment; a lack of resource evaluation related to quality for 
specific diseases; persisting variations among providers in care for similar patients; for 
most diseases, potential quality problems and their prevalence and incidence are 
unknown in many countries (Chassin and Galvin 1998; Schuster, McGlynn et al. 1998). 
 
In the health care field, measuring quality of care has traditionally relied on the structure-
process-outcome framework developed by Donabedian (Donabedian 1988). Avedis 
Donabedian identified the three dimensions that can be utilized to assess quality of care 
(structure, process, and outcome) that would later become the core divisions of the 
Donabedian Model. ―Evaluating the Quality of Medical Care‖ became one of the most 
frequently cited public health-related articles of the 20th century (Donabedian 2005). 
Donabedian defines structure, process, and outcome, and clarifies that these categories 
should not be mistaken for attributes of quality, but rather they are the classifications for 
the types of information that can be obtained in order to infer whether the quality of care is 
poor, fair, or good. Furthermore, he states that in order to make inferences about quality, 
there needs to be an established relationship between the three categories and that this 
relationship between categories is a probability rather than a certainty. Structure in health 
care delivery can refer to the physical plant or the organizational structure. Processes are 
specific patient interventions performed by health care professionals and resulting in an 
outcome. Some examples of processes are, use and timeframe of emergency endoscopy 
in acute upper bleeding and patient length of stay in the emergency department. 
Outcomes are the result of the patient's interaction with the delivery health care system. 
Examples of clinical outcome measures include mortality or length of stay, readmission 
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rates, morbidity measures such rebleeding after therapeutic endoscopy. Present 
measurement systems may focus on any one of the components. Clinical performance 
measurements, which include process and outcome measures, are in demand in health 
care today.  
  
Also indicators provide a quantitative basis for clinicians and organizations aiming to 
achieve improvement in care and the processes by which patient care is provided. 
Indicator measurement and monitoring serves many purposes. They make it possible to: 
document the quality of care; make comparisons (benchmarking) over time between 
places (e.g. hospitals); set priorities (e.g. organizing medical care); support QI. The use of 
indicators enables professionals and organizations to monitor and evaluate what happens 
to patients as a consequence of how well professionals and organizational systems 
function to provide for the needs of patients.  
 
Indicators allow the quality of care and services to be measured. This assessment can be 
done by creating quality indicators that describe the performance that should occur for a 
particular type of patient or the related health outcomes, and then evaluating whether 
patients‘ care is consistent with the indicators based on evidence-based standards of 
care. 
 
Clinical indicators (CIs) are a form of performance measurement, a method for assessing 
the quality of care by examining the incidence of specific events or incidents. Although 
similar performance measures have been utilized in health care since the 1980s, the call 
for CIs intensified after the concerns around patient safety (Thomson and Lally 1998). 
Clinical indicators can be part of, or linked to, broader health, quality, safety or 
performance indicators. The difference between CIs and broader indicators is that CIs are 
said to be more suitable for internal QI, while performance indicators are appropriate for 
external appraisals (Wollersheim H 2007). Data on clinical indicators have been 
developed, and the results compared, at international, national, regional, health systems, 
health services and individual clinician levels. Healthcare institutions may use CIs at any 
or all of these levels at any given time (Mattke, Epstein et al. 2006; McLoughlin, Millar et 
al. 2006). 
 
We find many definitions of CIs in the literature (table 3). According to Mainz, the use of 
indicators enables professionals and organizations to monitor and evaluate what happens 
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to patients as a consequence of how well professionals and organizational systems work. 
Indicators are, however, not a direct measure of quality (Mainz 2003).  
 
Table 3: Definitions of clinical indicators 
 
Mainz‘s definition 
(Mainz 2003) 
The United Kingdom‘s 
National Health Service 
definition 
(Collopy 2000) 
 
Australian Council on 
Healthcare Standards' 
definition 
(Rockville 2009) 
―... the measure the extent 
to which set targets are 
achieved. They are 
expressed as numbers, 
rates, or averages that can 
provide a basis for 
clinicians, organizations, 
and planners aiming to 
achieve improvement in 
care and the processes by 
which patient care is 
provided. They can be 
measures of structure, 
process, and outcome, 
either as generic measures 
relevant for all diseases, or 
disease-specific measures 
that describe the quality of 
patient care related to a 
specific diagnosis.‖ 
―… succinct measures that 
aim to describe as much 
about a system as possible 
in as few points as 
possible. Indicators help us 
understand a system, 
compare it and improve it.‖ 
18 At a similar level, 
clinical indicators have 
been described as ―… a 
measure of the clinical 
management and/or 
outcome of care‖. 
―... simply a measure of the 
clinical management 
and/or outcome of care. A 
well-designed indicator 
should ‗screen‘, ‗flag‘ or 
‗draw attention‘ to a 
specific clinical issue. 
Usually rate based, 
indicators identify the rate 
of occurrence of an event. 
Indicators do not provide 
definitive answers; rather 
they are designed to 
indicate potential problems 
that might need 
addressing, usually 
demonstrated by statistical 
outliers or variations within 
data 
results. They are used to 
assess, compare and 
determine the potential to 
improve care. Indicators 
are therefore, tools to 
assist in assessing 
whether or not a standard 
in patient care is being 
met.‖ 
 
 
 
 
 
Indicators should be based on the best available evidence. Sackett et al. describe this as 
‗the integration of best research evidence with clinical expertise and patient values‘. The 
strength of evidence for an indicator will determine its scientific soundness or the 
likelihood that improvement in the indicator will produce consistent and credible 
improvements in the quality of care (Sackett DL 2000). Namely, CIs measure the extent to 
which set targets are achieved. They are expressed as numbers, rates, or averages that 
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can provide a basis for clinicians, organizations, and planners aiming to achieve 
improvement in care and the processes by which patient care is provided. An initial step 
towards good measurement practice begins by realizing that indicators can be classified 
in many different ways and by identifying types of indicators that reflect the aspects of 
health care delivery we wish to measure. Ideally these concepts should be capable of 
capturing the Donabedian Model (Donabedian 2005). They can be measures of structure 
(the tools, resources, and organizational components), processes (activities that connect 
patients, physicians, and staff), and outcomes (results), either as generic measures 
relevant for all diseases, or disease-specific measures that  describe the quality of patient 
care related to a specific diagnosis. CIs can be categorized according to its purpose: rate-
base or sentinel; related to structure, process or outcome; generic or disease specific; 
type of care (preventive, acute or chronic); screening, diagnosis, treatment and follow-up. 
The six aims of improvement, identified by the IOM, can also be used to categorize CIs 
(Medicine 2001), as well as those from the WHO, described above. The decision as to 
which indicator is selected depends on the question we are trying to answer. For each 
concept, there are several different indicators that can be tracked, as exemplified in table 
4. 
 
  
Table 4: Example of CIs concept 
Concept 
 
Potential Indicators for this process 
Care of emergency acute upper bleeding 
patients 
 The total number of patients 
 The ED transfer rate 
 The percentage of ED patients 
admitted as inpatients 
 The patient wait time to 
endoscopy procedure  
 
 
After selecting a specific indicator, we create an operational definition. The next step is to 
develop a data collection plan; there are several important data collection issues that 
require some elaboration, most notably stratification and sampling. Stratification is the 
separation and classification of data according to selected identifiers. The objective of 
stratification is to create categories within the data to discover patterns that would not 
otherwise be observed if the data were aggregated together (e.g. day of the week; time of 
the day; time of the year; severity of the patient; referral vs. non-referral). So, if we want to 
organize our indicator development form we must be able to answer some questions: 1) 
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What process or outcome does this indicator measure?; 2) Why do I want to measure this 
indicator?; 3) Which objective does it satisfy?; 4) Which dimension of quality does it 
cover?; 5) Are there literature references for this indicator?. 
 
A frequently asked question is whether structure, process or outcome is the best measure 
of quality of care. Evaluations of quality that rely only on structural elements implicitly 
assume that well-qualified people working in well- organized settings will provide high-
quality care. Good outcomes can result even when the care is clearly deficient. The 
reverse is also possible: although the care is excellent, the outcome may not be a good 
one. Ultimately what a particular outcome tell us about quality of care depends crucially on 
whether the outcome can be attributed to the care provided. In other words, we have to 
examine the link between the outcome and the antecedent process and determine 
whether the care provided was appropriate and whether it was provided skillfully. Once it 
has been established that certain procedures used in specific situations or for certain 
patients are clearly associated with good results, the presence or absence of these 
procedures for such patients or situations can be accepted as evidence of good or bad 
quality. Such evidence-based structural or process indicators may be referred to as 
‗outcome validated‘ and represent direct measures of quality.  
 
Process indicators are especially useful when: QI is the goal of the measurement process; 
an explanation is sought for why specific providers achieve particular outcomes; short 
time frames are necessary; performance of low volume providers is of interest; and when 
tools to adjust or stratify for patient factors are lacking.  Comparisons of process data are 
easier to interpret and more sensitive to small differences than comparisons of outcomes 
data. A process indicator can measure whether or not an upper bleeding patient receives 
the right medication, whereas 30-day mortality rates may be difficult to interpret (Palmer 
1998; Mainz 2003).  
 
Palmer suggests that outcomes data are useful if : outcomes can be measured that are 
affected by health care; long time-frames are possible; performance of whole systems 
should be studied; or if a high volume of cases is available. Outcomes data are most 
useful for tracking care given by high-volume providers over long periods of time, and for 
detecting problems in implementation of processes of care (Palmer 1998) A reasonable 
strategy is to select measures that meet the needs of each particular condition or 
treatment; sometimes these will be structure or process measures, and sometimes 
outcomes measures. More often, they will be a combination of the two (Mainz 2003). 
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In practice, to assess quality, using structure, process or outcome measures, we need to 
know what constitutes good structure, good process, or good outcomes. We need criteria 
and standards for those aspects of care. Criteria refer to specific attributes that are the 
basis for assessing quality. Standards express quantitatively what level the attributes must 
reach, to satisfy the expectations about quality. 
 
Quality measurement and improvement in endoscopy are essential for the quality of care 
in gastroenterology. Publications have primarily addressed issues of technical quality and 
patient safety (Baron, Petersen et al. 2006; Cohen, Safdi et al. 2006; Faigel, Pike et al. 
2006; Jacobson, Chak et al. 2006; Rex, Petrini et al. 2006; Axon 2009; Coe, Raimondo et 
al. 2009; Colton and Curran 2009; Crispin, Birkner et al. 2009; Faigel and Cotton 2009; Ho 
and Wiersema 2009; Lieberman, Faigel et al. 2009; Polkowski, Gerke et al. 2009; 
Rembacken 2009; Siddiqui, Yang et al. 2009; Al-Haddad, Gill et al. 2010). The first 
guidelines or position statements on various aspects of quality and safety indicators have 
been developed by the British Society of Gastroenterology, the American Society for 
Gastrointestinal Endoscopy and the American College of Gastroenterology, the World 
Organization of Digestive Endoscopy, the International Agency for Research in Cancer 
and the Canadian Association of Gastroenterology. These guidelines are all procedure 
based. They don´t address patients needs and don't provide a framework for adoption in 
the overall context of endoscopic services. For example, in the British guidelines, quality 
and safety have been separated to highlight the difference between the benefits (quality) 
and harm (safety) of endoscopic procedures. The indicators have been separated further 
into two broad categories: relatively fixed items: structure, process and staffing and more 
dynamic indicators: auditable outcomes and quality standards. However, recognition of 
the need for great patient focus in health care has led to include other dimensions of 
quality: patient access to procedures; the appropriateness and timeliness of procedures, 
and patient's comfort and satisfaction. The most recent guidelines, like the Canadian 
ones, are patient-centered and try to cover the patients' journey (Armstrong, Barkun et al. 
2012).   
A comprehensive quality assurance program should incorporate quality across all aspects 
of endoscopy. One good example is the Global Rating Scale (GRS) which has been 
implemented in endoscopy departments throughout England and validated in Netherlands 
(Sint Nicolaas, de Jonge et al. 2012). The development of the GRS was prompted by the 
introduction of a colorectal cancer screening programme and by shortcomings in the 
quality of endoscopy (Bowles, Leicester et al. 2004; Radaelli, Meucci et al. 2008).  
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A national roundtable on health care quality, established in 1995 by the IOM stated that a  
comprehensive approach to measuring the quality of care requires attention to three 
different kinds of quality problems: too much care [overuse], too little care [underuse], and 
misuse [flaws and errors in technical and interpersonal aspects of care] (Medicine 1999):  
 a) Too Much Care: unnecessary or inappropriate care: an example of overuse 
include the excessive or unnecessary use of emergency endoscopy procedures; this 
practice may result in still further procedures (laboratory) and activities (patient transfer) in 
a cascade of interventions that might have been avoided and that might make patients 
vulnerable to harmful side effects with wasting of money and resources, that could be put 
to more effective use. 
 b) Too Little Care: underuse of needed, effective, and appropriate care: many 
studies have demonstrated the large gap between what is known to be effective care and 
what patients actually receive, as mentioned before about variability in clinical practice. 
 c) Misuse: shortcomings in technical and interpersonal aspects of care: inferior 
care results when the performance of health care professionals or support systems is 
inadequate. Examples include preventable endoscopic complications or failure to monitor 
or follow up those complications.  
 
In 2011, Katharine A. Germansky and Daniel A. Leffler, realizing that only endoscopy has 
been the focus of QI work, reviewed a variety of areas in clinical gastroenterology where, 
existing guidelines and published data suggest both, the need and viability of active 
quality assurance measures (Germansky and Leffler 2011). The authors suggested that 
as mortality rates for gastrointestinal bleeding remained stubbornly high, mortality rates 
should be monitored and case fatalities reviewed, ideally by a multidisciplinary team, in 
order to identify areas for improvement. Indeed, the authors referred to clinical audit. 
Clinical audit is a cyclical process, where standards are agreed and data collected. 
Findings from the analysis of collected data show whether or not standards are being met. 
If they are not being met, changes are planned and implemented, and data are collected 
for a second time and analyzed to see if any improvements have resulted from these 
changes. The definition of clinical audit, endorsed by the National Institute for Clinical 
Excellence is: clinical audit is a QI process that seeks to improve patient care and 
outcomes through a systematic review of care against explicit criteria and the 
implementation of change. Aspects of the structure, processes, and outcomes of care are 
selected and systematically evaluated against explicit criteria. Where indicated, changes 
are implemented at an individual, team, or service level and further monitoring is used to 
confirm improvement in healthcare delivery (NICE 2002). This means, the systematic 
approach encouraged by Deming. 
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Gastrointestinal endoscopy is a complex diagnostic and therapeutic activity that demands 
a high level of skill and knowledge on the part of the operator. However, high-quality 
endoscopy requires more than a skilled operator. The delivery of high-quality endoscopy 
services, in a cost-effective manner consistent with the broader needs of a health care 
system, requires a formal QI framework that addresses all aspects of endoscopy service 
delivery: from the patient‘s initial contact with a health care provider through to 
documentation of outcomes. Recognition of the patient as the focus of the endoscopy 
process provides a structure for integrating the efforts needed to ensure a high-quality 
service.  
 
So, measurement of health care quality serves a range of objectives, including the 
following: providing data to inform QI efforts; to know if a facility meets previously 
established standards; identifying and possibly eliminating substandard performance; 
monitoring and reporting information about changes in quality of care over time; and 
addressing the health needs. In general, either processes or outcomes may be valid 
measures of quality. For an outcome to be a valid measure of quality, it must be closely 
related to processes of care that can be manipulated to affect the outcome. Likewise, for a 
process to be a valid measure of quality, it must be closely related to an outcome. Each 
one plays a part in quality measurement. Structural measures of quality typically include 
the characteristics of the resources in the health care system, including individual 
practitioners, groups of practitioners, organizations and systems of care, geographic 
location, and accessibility of services. They are measures of the presumed capacity of the 
practitioner or provider to deliver quality health care. Peter Cotton  drew attention to this 
problem some years ago, in the endoscopy setting (Cotton 2011). Endoscopists cannot 
work without good facilities, equipment, and a team of well-trained and motivated staff; so, 
one point that must attract our attention relates to the metrics of quality in endoscopy 
units. Measures of performance may include interpersonal aspects of care, service, 
timeliness, and convenience. Technical aspects of care include the timeliness and 
accuracy of diagnosis, the appropriateness of therapy, complications, and mishaps during 
treatment, and coordination of care across delivery settings. Errors in carrying out the 
complex series of steps often involved in patient care may contribute to preventable 
deaths or failures. Health outcomes include the traditional measures of survival 
(expressed as risk-adjusted mortality), unintended effects of treatment (e.g., perforation), 
and the relief of symptoms. Such measures may be specific to a given health problem and 
may focus on other outcomes (e.g., thirty-day survival, complications from disease, or free 
of bleeding after successful therapeutic endoscopy).  An outcome measurement is in 
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some ways the ultimate form of quality measurement because, what interests most people 
is whether care has improved the patient's health. Nevertheless, the pitfalls are great; to 
be useful for QI, outcomes data need to provide information with a high level of clinical 
detail and be provided in a sufficiently clear manner that providers can know what 
processes must be changed.  
Many, in the health care system have begun to apply a model of QI called continuous QI 
or total quality management. One assumption of this model is that the health care 
organizations and systems within which professionals practice can always improve. One 
way to acquire this improvement is to set up continuous monitoring systems that alert the 
organization when performance in some area is slipping or to confirm that efforts at 
improving care are succeeding, or both.  
Assessing the effectiveness of health care, clearly requires the measurement of health 
improvement—the difference in health with and without some intervention. Most countries, 
like Portugal, face high demands on their health care systems and a limited budget to 
meet these demands. Clinicians often face situations where there is information 
demonstrating the benefits from an intervention or treatment, but, there is still little context 
in which to understand how much their patients will value these benefits and whether the 
benefits are significant enough to merit expending scarce resources. Furthermore, it could 
be argued that it is an ethical responsibility to consider these issues as the savings on 
spending could be directed to other areas of health with greater efficiency. However, the 
need to assess the ―economic‖ gain from alternative forms of care is reflected in the 
continuing development of economic evaluation methods and the increasing numbers of 
studies with health economic input. Compilers of clinical practice guidelines are also 
placing more emphasis on economic data. Economic evaluations of interventions are 
central to informing the advice and decisions issued by organizations such as the UK‘s 
National Institute for Clinical Excellence. That is, organizations are concerned with issues 
of cost-effectiveness and cost-benefit. One of the foremost organizations in the pursuit of 
rigorous evidence on the effectiveness of interventions is the Cochrane Collaboration – an 
international organization with the aim of improving the effectiveness of health care 
throughout the world by preparing, maintaining and making accessible systematic reviews 
of the effects of health care.  
 
Economic assessments have become an integral part of policy decisions on healthcare, 
because expenditures on health care in developed countries have risen faster. 
Consequently, health-care expenditure has been consuming an ever-larger share of the 
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total economy, and politicians have to balance the optimum level of expenditures on 
health care. Economic evaluation can assess whether one particular intervention is worth 
undertaking compared to another intervention (or compared to doing nothing). Economic 
evaluation analyzes whether the additional benefits of an intervention are greater than the 
additional costs. In economic analyses, costs are typically categorized as ―direct medical‖, 
―direct non-medical‖, and ―indirect costs of lost productivity‖. In financial or accounting 
analyses, costs are classified differently, as ―variable‖ or ―fixed‖. Variable costs, such as 
the physician‘s time and drugs administered, vary dependent on the numbers of cases 
treated, whereas fixed costs do not vary in the short-to medium term and are unlikely to 
change with any fluctuations in the number of cases (e.g., the cost of a building). Some 
health economists do use accountancy terms such as ―fixed costs‖ but this is not a serious 
problem so long as the costs that are included are those appropriate for the perspective 
chosen and reflect the opportunity costs (Meltzer 2001). The maximum possible reduction 
in a disease due to the use of an intervention is termed the efficacy of the intervention. 
Efficiency evaluates how well resources are used to achieve a desired outcome. It has a 
number of different aspects: allocative efficiency measures the extent to which resources 
are allocated to the groups or individuals who can benefit most. For example, the benefits 
of urgent endoscopy provided in the first two hours to high-risk patients are far in excess 
of the benefits that arise when it is done in low-risk patients; allocative efficiency therefore 
requires the high-risk patients to be targeted as a priority, resulting in an improved level of 
health associated with very early emergent endoscopy; technical efficiency measures 
either the extent to which resources are combined to achieve maximum outcome, or 
alternatively the minimum amounts of resources that are combined to achieve a given 
outcome (for example, identifying the least expensive way to effectively treat a bleeding 
peptic ulcer; in this case, doing an unnecessarily second-look endoscopy or long courses 
of drugs or unnecessarily expensive drugs implies the existence of technical inefficiency. 
 
Since the objective of economic appraisal is to seek efficient and equitable uses of 
resources it is important that all potentially efficient and equitable options should be 
examined. The options examined have to be selected as being those considered to offer 
the greatest potential. This again emphasizes how economic appraisal builds on 
epidemiological evaluation and clinical trials. For example, an economic appraisal of an 
out-of-hours endoscopy program in the North of Portugal, could examine the alternatives 
of: no program; a large regional program; a program for old people only;  for one city;  for 
every city; for three cities; a program for one or two year; a program phased over several 
years. Ultimately the appraisal objective is to seek social efficiency and equity. However, 
when there is a constraint on the resource budget, seeking the most technically efficient 
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(maximum benefit) way of spending will be the objective. Where there is a fixed benefit or 
health effect to be achieved, the objective is to seek the most technically efficient—i.e. 
least cost—way.  
 
Economic evaluation uses information on the costs and outcomes of different treatments 
to guide choices among competing demands for health care resources. We have limited 
resources, so have to choose between health services; health economics offers 
systematic ways to guide these choices. The three main methods used to assess the 
economics of an intervention in healthcare are: cost-benefit analysis (CBA), cost-
effectiveness analysis (CEA), and cost-utility analysis (CUA). The central purpose of CEA 
is to compare the costs and the values of different health care interventions in creating 
better health and longer life. Many new medical devices, procedures, diagnostic tests, and 
prescription drugs are expensive; cost-effectiveness analysis can help to evaluate 
whether the improvement in health care outcomes justifies the expenditures relative to 
other choices. This understanding of the costs and outcomes of comparative interventions 
is essential for decision makers to make informed decisions about using health care 
resources efficiently. Questions of technical efficiency are addressed using CEA. The 
CBA in health care is the analysis of health care resource expenditures relative to 
possible medical benefit. This analysis may be helpful and necessary in setting priorities 
when choices must be made in the face of limited resources. This analysis is used in 
determining the degree of access to, or benefits of, health care to be provided. A 
particular form of CEA that is becoming more widespread in health care is where the 
benefits/health effects are expressed in terms of ‗quality-adjusted-life-years‘ (QALYs) 
gained. This particular form of CEA is called CUA. In CUA the health effects of a project 
are expressed on a 0–1 scale of quality adjusted life for each time period, and the tangible 
outcomes/resource consequences in monetary terms. The overall effects of projects are 
set in terms of ‗cost per QALY gained‘.  
 
In conclusion, quality of care is a complex interaction between processes of care, clinical 
and patient oriented health outcomes and the productivity of a health care system (figure 
4). 
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Figure 4: Factors determining the outcome of care in health care delivery
Adapted from International Journal for Quality in Health Care 2003
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II. BACKGROUND 
 
IIb. Non-Variceal Acute Upper Gastrointestinal Bleeding 
 
 
NVAUGIB is a prevalent, clinical significant and expensive healthcare problem. It is 
the leading cause of urgent gastroenterology consultations and despite considerable 
advances during the last decades, NVAUGIB remains one of the most serious and 
potentially life-threatening medical cases that require hospitalization and careful 
monitoring of the patients (Gilbert 1990; Longstreth 1995; Rockall, Logan et al. 1995; 
Rockall, Logan et al. 1996). 
 
 
Bleeding may be caused by many different lesions of variable prognostic importance. 
AUGIB is categorized as NVAUGB or variceal, depending on the aetiology. The vast 
majority of AUGB is secondary to non-variceal causes, with peptic ulcers being the most 
prevalent cause, followed by gastroduodenal erosions, Mallory-Weiss tear, esophagitis 
and Dieulafoy‘s lesions.  
NVAUGIB is expected to rise with older demographics and the increased consumption of 
many drugs, such as non-steroidal anti-inflammatory drugs6,7. These drugs intensify the 
risk of peptic ulcer complications, mainly bleeding, in patients with a peptic ulcer history. 
Elderly patients constitute a subgroup with special characteristics who need careful 
handling during their hospitalization, because it is a population with considerable co-
morbidity, higher medication use and greater risk for further complications. Validated 
prognostic scoring systems, based upon the severity of bleeding, diagnosis, endoscopic 
findings and extent of co-morbidities, predict mortality and have clinical utility8,9. 
Approximately 45%-60% of the admissions for AUGIB worldwide are due to peptic ulcers.  
 
The treatment of NVAUGIB is based upon cardiovascular resuscitation followed by 
endoscopic therapy in patients with active bleeding or major stigmata of recent 
haemorrhage. Emergency surgery is undertaken for uncontrolled bleeding or re-bleeding 
that cannot be controlled by further endoscopic therapy. Early endoscopy (within the first 
24 hours for NVAUGB) with risk classification by clinical and endoscopic criteria, allows 
for safe and prompt discharge of patients classified as low risk, improves patient 
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outcomes for patients classified as high risk, and reduces use of resources for patients 
classified as either low or high risk.  
 
NVAUGIB can be defined in three words: common, costly, and potentially life-threatening. 
So it must be managed promptly and appropriately to be effective and prevent adverse 
outcomes. Balancing these roles in the light of increasing patient volume, ageing 
population and limited resources we face a new challenge in the emergency setting. 
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II. BACKGROUND 
 
IIb. Non-Variceal Acute Upper Gastrointestinal Bleeding 
 
IIb1. Occurrence and Mortality Trends 
 
AUGIB is the commonest cause of acute hospital admission to gastroenterology and 
therefore has a large impact on the acute medical admission workload. Changes in 
management have been shown in randomized controlled trials to improve outcome from 
gastrointestinal hemorrhage, but the largest observational studies of mortality trends 
following upper gastrointestinal hemorrhage report no improvement in overall mortality 
over the last 2 decades (van Leerdam, Vreeburg et al. 2003; Thomopoulos, Vagenas et 
al. 2004; Targownik and Nabalamba 2006; Loperfido, Baldo et al. 2009). The population-
based study of patients hospitalized because of gastrointestinal complications in 10 
general hospitals between 1996 and 2005 in Spain, performed by  Lanas et al. (Lanas, 
Garcia-Rodriguez et al. 2009),  demonstrated a progressive change in the overall picture 
of gastrointestinal bleeding (GI) events leading to hospitalization, with a clear decreasing 
trend in upper GI events and a significant increase in lower GI events, causing the rates of 
these two GI complications to converge. Overall, mortality has also decreased, but the in-
hospital case fatality of upper or lower GI complication events has remained constant. 
According to the author, it will be a challenge to improve future care in this area, as well 
as reducing their associated mortality. Another study, from Netherlands, also examined 
time trends in incidence and outcome of upper GI bleeding (van Leerdam, Vreeburg et al. 
2003). They reported that incidence decreased from 61.7/100,000 in 1993/94 to 
47.7/100,000 persons annually in 2000, corresponding to a 23% decrease in incidence 
after age adjustment (95% CI = 15-30%). The incidence was higher among patients of 
more advanced age. However, rebleeding (16% vs. 15%) and mortality (14% vs. 13%) did 
not differ between the two time periods. Also, among patients with ulcer bleeding, 
rebleeding (22% vs. 20%) and mortality (15% vs. 14%) did not differ between the two time 
periods. Increasing age, presence of severe and life-threatening comorbidity, and 
rebleeding were associated with higher mortality. Another study from Greece, compared 
the etiology and clinical outcome of AUGIB, between two distinct periods, during 15 years: 
668 patients hospitalized with the problem in 1986-1987 were compared to 636 patients 
with AUGIB in 2000-2001. Overall mortality was also reduced from 5.2% to 3.1% and in 
peptic ulcer bleeding patients from 3.3% to 2.4%, respectively, but the differences were 
not statistically significant (Thomopoulos, Vagenas et al. 2004). Also a Greek study, 
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estimated the incidence of AUGIB and peptic ulcer bleeding (PUB) in two different 
periods, 1995 and 2005. A reduction in the incidence of AUGIB from 162.9/100,000 
population in 1995, to 108.3/100,000 population (rate ratio=0.49, confidence interval 
95%=0.37-0.63) in 2005 and in the incidence of PUB from 104.8/100,000 population to 
72.5/100,000 (rate ratio=0.49, confidence interval 95%=0.35-0.68) were, respectively, 
observed. The authors concluded that although the incidence of AUGIB significantly 
decreased, patients were older with more comorbidities, and mortality remained 
unchanged (Theocharis, Thomopoulos et al. 2008). The French also evaluated the main 
changes in characteristics, practices and outcome between 1996 and 2000 in patients 
admitted for an acute upper gastrointestinal hemorrhage (variceal and non-variceal 
hemorrhage); they observed a significant decrease in AUGIB mortality in the whole group 
(11.7 versus 7.2%; P=0.03), and particularly in the subgroup of cirrhotic patients (19.5 
versus 11.1%; P=0.05) whatever the source of their bleeding (Di Fiore, Lecleire et al. 
2005). A retrospective non-randomized clinical study performed during 2011 that took 
place at the Regional Institute of Gastroenterology and Hepatology in Cluj Napoca, 
revealed an important decrease in the need for urgent haemostatic surgery despite a 
relatively constant general mortality rate. Comparing data from 2011 with data from 2002 
in the same hospital, they noticed a decrease by half for urgent haemostatic surgery in 
cases of non-variceal bleeding. In 2002, the need for urgent haemostatic surgery was 
7.9% for non-variceal bleeding with a drop from 17% in 1989. In 2011, need for urgent 
surgery was 3.68%. The mortality rate was similar to previously data, reaching 
approximately 10%, remaining constant (Botianu, Matei et al. 2013). A single-center study 
from Italy, compared 587 patients who presented with AUGIB during the 1983-to-1985 
period, with 539 patients in the 2002-to-2004 period. The overall incidence of AUGIB 
decreased from 112.5 to 89.8 per 100,000/y, which corresponds to a 35.5% decrease 
after adjustment for age (95% CI, 24.2%-46.8%). The age standardized incidence of ulcer 
bleeding decreased by 41.6% (95% CI, 27.2%-56%); the decrease occurred only in 
people younger than 70 years of age. Rebleeding rates decreased from 32.5% to 7.4% (P 
< .001) and surgery from 10.2% to 2.0% (P < .001). Overall mortality decreased from 17.1 
to 8.2 per 100,000/y, which corresponded to a 60.8% decrease after adjustment for age 
(95% CI, 46.5%-75.1%). The age standardized mortality rate for ulcer bleeding decreased 
by 56.5% (95% CI, 41.9%-71.1%). The explanation for these data was that, advances in 
medical practice in recent decades have influenced the etiology and management of 
AUGIB (Loperfido, Baldo et al. 2009). In 2007, a study from Canada, confirmed the 
decrease in incidence from NVAUGIB; between 1993 and 2003, NVUAGIB incidence 
decreased from 77.1 cases to 53.2 per 100,000/y for the broad definition, and from 52.4 to 
34.3 cases per 100,000/y for the narrow definition (ICD-9/ICD-10-based definition). 
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Although the proportion of NVAUGIB subjects requiring surgical intervention declined over 
the 10 years from 7.1% to 4.5%, the mortality rate remained steady at approximately 
3.5%; but they only identified deaths that occurred before discharge (Targownik and 
Nabalamba 2006). The low mortality identified in this study (3.5%) is similar to other North 
American (Zhao Y.) and Mediterranean (Lanas, Garcia-Rodriguez et al. 2009) studies but 
is much lower than the European studies previously cited (van Leerdam, Vreeburg et al. 
2003; Di Fiore, Lecleire et al. 2005; Loperfido, Baldo et al. 2009; Botianu, Matei et al. 
2013). So, the studies with mortality reduction did not report variceal and non-variceal 
hemorrhage mortality trends separately or trends in different age and comorbidities. Other 
non-variceal hemorrhage studies from Spain, The Netherlands, Greece, Romania and 
France, with the exception of the Italian one, did not identify reductions in non-variceal 
inpatient mortality. Although these were large studies, none of them identified deaths that 
occurred after discharge because outcome was just analyzed in terms of in-hospital 
death.  
 
More recently, a case control study, estimated trends in 28-day mortality in England 
following hospital admission for gastrointestinal hemorrhage. They used a case-control 
study design to analyze data from all adults administered to a National Health Service 
hospital, for upper gastrointestinal hemorrhage, from 1999 to 2007 (n=516,153). Cases 
were deaths within 28 days of admission, and controls were survivors to 28 days. The 28-
day mortality was derived from the linked national death register. A logistic regression 
model was used to adjust trends in non-variceal and variceal hemorrhage mortality for 
age, sex, and comorbidities and to investigate potential interactions. The mortality in this 
study improved right up to the end of the study period. The authors clarified some reasons 
for the reduction in mortality: there were similar reductions in mortality whether or not an 
endoscopy was recorded and for all associated diagnoses, implying that endoscopic 
therapy was not a major contributor to the reduction in mortality; that improvement in 
standard non-endoscopic care has led to improved survival, such as the routine 
administration of intravenous proton pump inhibitor infusions, the routine use of risk 
scoring, the implementation of standardized clinical guidelines, and the subsequent local 
auditing of practice (Palmer 2002; Gralnek, Barkun et al. 2008; 2010; Barkun, Bardou et 
al. 2010). 
 
 It is important to notice that differences in practice may confound comparisons between 
countries. Even in the same country, variability in patient's management is observed 
(Hearnshaw, Logan et al. 2010). Nevertheless, an European Survey of Nonvariceal Upper 
Gastrointestinal Bleeding (ENERGIB) concluded that differences in outcomes of 
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NVAUGIB reported across countries did not seem to be due to differences in clinical 
management or health organizations, at least within a European setting (Lanas, Aabakken 
et al. 2011). ENERGIB was an observational, retrospective cohort study carried out 
across multiple centers in seven countries (Belgium, Greece, Italy, Norway, Portugal, 
Spain and Turkey). A target sample size of 400 patients per country was established and 
123 centers participated in the study, with the following distribution per country: Belgium 
(26 centers), Greece (10), Italy (11), Norway (16), Portugal (12), Spain (24) and Turkey 
(24). A total of 2664 patients were included in the study, and 2660 patients were eligible 
for the statistical analyses. They evaluated a number of variables possibly associated with 
outcomes of NVAUGIB including clinical predictors, management strategies and 
healthcare resource utilization in a 'real-world', European, clinical practice setting. This 
report focused on the predictors of poor outcomes of NVAUGIB in terms of bleeding 
continuation/re-bleeding and mortality. Overall, 12.3% of patients experienced bleeding 
continuation/re-bleeding within 30 days of the initial NVAUGIB episode. Continued 
bleeding was observed in 7.3% of patients, while 10.5% of patients experienced re-
bleeding within 30 days. The proportion of patients undergoing surgery (other than 
endoscopy) to control bleeding was low, at 3.3%. The mortality rate within 30 days of the 
bleeding event was 5.2%. The ENERGIB study therefore confirmed that mortality 
associated with NVAUGIB has not decreased substantially in recent years, despite 
advances in endoscopic and pharmacological therapies. There are some methodological 
limitations in this retrospective study that must be considered: all patients were treated 
according to the standard clinical care protocol at each participating study site; the 
practice of retrospective collection of data through clinical records, make it particularly 
difficult to check and unreliable. Other factors that have been linked to fatality rates in 
AUGIB such as, social deprivation or day of the week of hospitalization, have not been 
considered (Lanas, Aabakken et al. 2011). It is difficult to understand how different 
processes produced similar outcomes. If this was the question this time round, the answer 
came afterwards. In 2012, Lanas et al. tackled the problem of variability in the 
management of NAVUGIB in Europe by effectively identifying the processes (Lanas, 
Aabakken et al. 2012). The results showed a wide between-country variability in the area 
and specialty of the NAVUGIB management team and unit transfer rates after the initial 
hospital assessment. The mean time from admission to endoscopy was <1 day only in 
Italy and Spain. Wide variation in the use of pre-endoscopy (35.0-88.7%) and relatively 
consistent (86.5-96.0%) post-endoscopic pharmacological therapy rates were observed. 
There was substantial by-country variability in the rate of therapeutic procedures 
performed during endoscopy (24.9-47.6%). NVAUGIB-related healthcare resource 
consumption was high and variable (days hospitalized, mean 5.4-8.7 days; number of 
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endoscopies during hospitalization, mean 1.1-1.7). The authors concluded that ENERGIB 
demonstrated that there were substantial differences in the management of patients with 
NVAUGIB episodes across Europe, and that in many cases the guideline 
recommendations for the management of NAVUGIB were not being followed. 
 
A total of 404 Portuguese patients from twelve hospitals, with NVAUGIB were included in 
ENERGIBE study, with a mean age of 68.5±17.1 years. The clinical risk score evaluated 
by the expected clinical risk scales (Rockall, Blatchford or ASA scales) was not registered 
in any of the Portuguese patients‘ clinical records. The mortality rate was 4.8% and, only 
in four cases, was directly related to the bleeding episode. Data were collected 
retrospectively from patients‘ medical records and so, many data were missed, like the 
endoscopy timeframe (Fonseca, Alves et al. 2012). Another retrospective Portuguese 
study, analyzed data from 597 patients admitted with AUGIB between August,1974 and 
August,1979 and reported a mortality rate of 10% and 6% for AUGIB and NVAUGIB, 
respectively (Carlos Sofia 1981). A  prospective, six year study, to evaluate the adequacy 
of a simple "Numerical Risk Score", proposed by the National Audit of Acute Upper 
Gastrointestinal Hemorrhage (United Kingdom), for a population of 372 high risk patients 
admitted to a Gastroenterological Intensive Care Unit with peptic ulcer bleeding, was 
conducted in Portugal and published in 1999. The mortality rate was 3,4%, 9,7% and 
19,4% for ward inpatients, intensive care patients and surgery patients, respectively (José 
Manuel Romãozinho and Ernestina Camacho 1999). I am unaware that there are more 
studies published in Portugal. 
The results of 1402 surveys of emergency physicians, internists, and gastroenterologists 
practicing in USA hospitals were as follows: there was no difference in the application of 
the quality indicators by specialty or clinical position. Among all physicians, 53% had ever 
heard of and 30% had ever used a risk score. More gastroenterologists than non-
gastroenterologists had heard of (82% vs. 44%, P<0.001) and used (51% vs. 23%, 
P<0.001) a risk score. There was no difference between attending physicians and 
trainees. Gastroenterologists and attending physicians more often cited lack of utility as a 
reason to not use risk scores, whereas non-gastroenterologists and trainees more often 
cited lack of knowledge. They concluded that, although the agreement with AUGIB initial 
management guidelines was high but adherence-especially pertaining to the use of risk 
scores was low (Liang and Saltzman 2014). 
 
So, in general, the failure to demonstrate a clinical improvement in NVAUGIB may be due 
to, either clinical guidelines not being followed or patient‘s characteristics have changed. 
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This latter explanation, with increasing age and comorbidity has been proposed as the 
likely explanation. For instance, if in some acute emergencies, such as heart attacks, the 
most common cause of death relates to the associated cardiovascular disease, but in 
other emergencies, such as stroke, death is commonly associated with other causes, 
such as cardiovascular disease and respiratory infections (Bronnum-Hansen, Jorgensen 
et al. 2001; Vernino, Brown et al. 2003).  
 
However, despite NVAUGIB being one of the most common gastroenterology reasons for 
admission in acute medicine, the outcomes of patients who have experienced a NVAUGIB 
episode are poorly understood in the context of the process of care. Therefore, to identify 
which interventions may possibly reduce mortality, we must analyze the impact of several 
factors in health care delivery system, which may vary from system to system.  
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II. BACKGROUND 
 
IIb. Non-Variceal Acute Upper Gastrointestinal Bleeding 
 
IIb2.  Interventions That Work 
 
As we have shown, although some data suggest a reduction in the incidence, the clinical 
burden and economic costs of NVAUGIB remain high (van Leerdam, Vreeburg et al. 
2003; Ahsberg, Ye et al. 2011; Lanas, Garcia-Rodriguez et al. 2011). 
 
The initial assessment is to determine whether the patient requires urgent intervention 
(e.g., endoscopic, surgical, transfusion) or can undergo delayed endoscopy or even be 
discharged to outpatient management. 
 
Although numerous factors from the patient history, physical examination, and initial tests 
have been examined for an association with a need for intervention, no single factor is 
sufficiently predictive of NVAUGIB severity to be used for triage. The most predictive 
individual factors are a history of malignancy or cirrhosis, (Adamopoulos, Baibas et al. 
2003) presentation with hematemesis, (Adamopoulos, Baibas et al. 2003; Aljebreen, 
Fallone et al. 2004) and signs of hypovolemia including hypotension, (Stoltzing, Ohmann 
et al. 1991; Adamopoulos, Baibas et al. 2003) tachycardia and shock, and a hemoglobin 
<8 g/dL. (Adamopoulos, Baibas et al. 2003; Aljebreen, Fallone et al. 2004) Some factors, 
such as a history of aspirin or no steroidal anti-inflammatory use, may not be useful for 
immediate disposition but are still important to assess for future management [e.g., if 
peptic ulcer disease] (Stoltzing, Ohmann et al. 1991).  
 
Patients who have significant comorbidities may require admission regardless of the 
severity of the NVAUGIB.  
 
In fact, many risk factors are associated with bleeding, and these must be addressed.  
Endoscopic intervention reduces the rate of rebleeding, the need for surgical intervention, 
and mortality in high-risk patients.  
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II. BACKGROUND 
 
IIb. Non-Variceal Acute Upper Gastrointestinal Bleeding 
 
IIb3.   Interventions That Need More Study: controversies and areas of 
uncertainty 
 
There are a few issues that are still unresolved with regard to the patient's assessment, 
pré-endoscopic and endoscopic: 
 
Risk Stratification Scoring System 
 
The most consistently reported predictors of mortality and re-bleeding in NAVUGIB have 
been age, number of comorbid conditions and hemodynamic instability (Barkun, Bardou et 
al. 2003; Marmo, Koch et al. 2008; Lanas, Aabakken et al. 2011), but, in order to 
standardize and improve care, various scoring systems have been developed to identify 
those individuals at high risk of requiring treatment, rebleeding or death. Early stratification 
of patients into high and low-risk categories allows the identification of individuals who 
may benefit from earlier interventions or those who can safely be discharged after 
endoscopy (Gralnek, Barkun et al. 2008; 2010; Barkun, Bardou et al. 2010). The 
International Consensus Recommendations on the management of patients with 
NVAUGIB recommend ―early risk stratification‖, by using validated prognostic scales in all 
patients (Barkun, Bardou et al. 2010; Sung, Chan et al. 2011). 
 
There are well-validated risk stratification scoring systems in the setting of NVAUGIB that 
helps to stratify patients into low-risk or high-risk patients, thus, influencing decisions 
regarding hospitalization versus prompt safe discharge from the emergency department 
(ED), and possibly influencing the ideal time to perform endoscopy (Laine and Jensen 
2012). There are two types of scores: those requiring endoscopy and those not requiring 
endoscopy (table 5).  
 
The Rockall score, described in 1996 following analysis of data from a large English audit, 
can be calculated using both pre-endoscopic [clinical Rockall; total = 7] and post-
endoscopic data [total = 11]. The full Rockall score incorporates both pre- and post-
endoscopic parameters. It predicts risk for further bleeding and mortality using age [<60, 
60-79, and >70 years], the presence of shock [systolic blood pressure <100 mmHg and 
/ Chapter II- Background 
 
102 
heart rate >100 beat/min], comorbidities [ischemic heart disease, congestive heart failure, 
any major comorbidities; and renal or liver failure and disseminated malignancy], and 
endoscopic diagnosis [Mallory–Weiss tear, peptic ulcer, erosive disease, esophagitis, or 
evidence of malignancy], along with endoscopic findings [blood in stomach, adherent clot, 
visible vessel, and spurting vessel or pigmented spot or no stigmata] (Rockall, Logan et al. 
1996). Patients with risk scores of 0 and 1 have low incidences of rebleeding and no 
associated mortality; allowing the identification of patients at low risk of complications for 
early discharge (Rockall, Logan et al. 1996). Is the most widely used scoring system, 
validated by several studies. The Glasgow Blatchford score (GBS) was developed to 
predict the need for intervention in UGIB, that is, transfusions, endoscopic therapy, and 
surgery. It's a non-endoscopy score, using only clinical and laboratory data (Blatchford, 
Murray et al. 2000). The American Baylor score was developed in 1993 to predict 
rebleeding after endoscopic therapy and includes five clinical and endoscopic variables 
(Saeed, Winchester et al. 1993). The Cedar Sinai predictive index predicts outcome and 
length of hospital stay; it includes endoscopic findings, hemodynamics, comorbidities and 
time from symptoms (Hay, Maldonado et al. 1997). The Almela score was developed to 
identify a low risk group suitable for out-patient management(Almela, Benages et al. 
2004). The Italian score was developed to predict mortality (Marmo, Koch et al. 2010).  At 
present, the Rockall score is the most widely used and studied post-endoscopy score to 
predict outcome.  
 
The GBS was developed in 2000 to predict the need for hospital based intervention 
(transfusion, endoscopic therapy, or surgery) or death (Blatchford, Murray et al. 2000). 
Romagnuolo et al. described a modified GBS (excluded serum urea and a history of 
syncope), easier to use in clinical practice (Romagnuolo, Barkun et al. 2007).  
 
The Cambridge score requires 14 clinical and laboratory variables and has not been 
externally validated (Cameron, Pratap et al. 2002).  
The AIMS65, a simple risk score has been developed and validated (Saltzman, Tabak et 
al. 2011; Chandra 2013; Hyett, Abougergi et al. 2013). The following parameters are 
used: age less than 65 years, systolic blood pressure 90 mmHg or lower, altered mental 
status, albumin less than 3.0 g/dL, and INR greater than 1.5. For those with no risk 
factors, the mortality rate was 0.3% compared with 31.8% in patients with all 5 (P < 
0.001).  
 
The GBS and the Clinical Rockall score have been examined in several studies and may 
determine the need for urgent endoscopy. In 3 studies comparing clinical prediction rule 
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scores in the same study population, the GBS performed better than the Clinical Rockall 
score for predicting patients at high risk for clinical intervention (Chen, Hung et al. 2007; 
Stanley, Ashley et al. 2009; Srirajaskanthan, Conn et al. 2010). A systematic review and 
quantitative appraisal of 16 prediction scores in gastrointestinal bleeding, concluded that 
methodological quality was suboptimal (de Groot, Bosman et al. 2012). The authors 
suggested that clinicians should use the ―best available‖ scores according to performance 
and quality, until new prediction scores of higher quality have been developed. These 
include, the GBS for predicting whether an intervention for acute gastrointestinal bleeding 
is required and, the scores of Villanueva et al. (Villanueva, Balanzo et al. 1993), Guglielmi 
et al. (Guglielmi, Ruzzenente et al. 2002) , and Chiu et al. (Chiu, Ng et al. 2009) for 
predicting a poor outcome, rebleeding rate, and mortality, respectively, according to 
endoscopic features. The results of this systematic review emphasized the need for high 
quality prediction scores in gastrointestinal bleeding. 
 
In conclusion, stratification of the risk of complication or death can optimize management 
and improve patient outcomes, while ensuring adequate resource allocation. The ideal 
prognostic score should be accurate, simple, reproducible, and prospectively validated in 
different populations. Published scores meet these requirements only partially, and thus 
can only be used as part of an integrative diagnostic and therapeutic process. 
 
Table 5: Risk Stratification Scoring Systems. 
 Endoscopy 
Required? 
Number of 
Variables 
Predicts 
Full Rockall Yes 6 Rebleeding and Mortality 
Baylor Yes 5 Rebleeding after 
endoscopic therapy 
Cedars Sinai Yes 6 Outcome and length of 
hospital stay 
Almela  Yes 3 Early discharge 
PNED 
Progetto Nazionale 
Emorragie Digestive 
 
Yes 
 
10 
 
Mortality 
Admission Rockall No 4 Early discharge 
Glasgow Blatchford No 8 Need for hospital based 
intervention and mortality 
Modified Blatchford No 5 Need for hospital based 
intervention and mortality 
AIMS65  No 5 Mortality 
 
Modified from Adrian J Stanley, World J Gastroenterol 2012 
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The Optimal Timing For Endoscopy 
 
Endoscopy has a clearly-defined role in the primary management of NVAUGIB (Hwang, 
Fisher et al. 2012). The endoscopic haemostatic therapy for NVAUGIB is indicated for 
patients having ulcers with high risk bleeding stigmata such as active bleeding or no 
bleeding visible vessels. The endoscopist can choose the haemostatic method according 
to the type, size, ulcer base characteristics, and location of the lesion. Injection therapy 
using epinephrine, ethanol, or hypertonic saline, thermal coagulation using contact and 
noncontact devices has been common choices in NVAUGIB with good outcomes. 
Endoscopic mechanical modalities currently available can provide secure bleeding control 
in most cases. Endoscopic hemostasis using a combination of currently available methods 
is preferred to monotherapy, especially to injection therapy alone, considering the 
synergistic effect of each modality having different mechanism of action. 
 
Appropriate indications for some therapeutic endoscopic interventions are well established 
and there has recently been increasing consensus regarding when and how the various 
methods for controlling bleeding should be deployed. But, although timing of endoscopy 
plays an important role in the diagnosis, risk stratification and treatment of AUGIB, the 
optimal timing for this investigation is still unclear. Service provisions for out-of-hours 
endoscopy are highly variable, and offering 24-hour endoscopy across all institutions may 
have serious economic implications. Evidence-based consensus guidelines recommend 
endoscopy within 24h (Barkun, Bardou et al. 2010; Laine and Jensen 2012). Very early 
endoscopy [<12 h] when compared with early endoscopy [>12 h and < 24 h] does not 
seem to confer any additional benefits in terms of rebleeding, need for surgery, or 
mortality in unselected patients with NVAUGIB based on randomized trial findings (Lin, 
Wang et al. 1996; Bjorkman, Zaman et al. 2004; Lim, Ho et al. 2011). However, Lim et al., 
suggested, using observational data, that endoscopy within 13 h of presentation was 
associated with a lower mortality in selected high-risk patients, defined as GBS > 12 (Lim, 
Ho et al. 2011). So, although some authors propose that endoscopy should be carried out 
within 12 h in acutely ill patients, this is supported by limited data (Lin, Wang et al. 1996; 
Lim, Ho et al. 2011) and is currently controversial (Barkun, Bardou et al. 2012). 
Furthermore, early endoscopy may identify those patients who can be safely discharged 
immediately after endoscopy, or, when combined to other factors, promptly and safely 
discharge patients already hospitalized (Forssman 1976; Moreno, Jaurrieta et al. 1998; 
Chaparro, Barbero et al. 2010; Rotondano, Cipolletta et al. 2014). In fact, early endoscopy 
within 24 h of presentation following successful resuscitation is recommended for patients 
with NVAUGIB (Barkun, Bardou et al. 2010). A recent review aimed to evaluate the 
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optimal timing of early endoscopy by examining the findings of randomized clinical trials 
and retrospective cohort studies that used comparable outcome measures and have been 
reported in the literature (Tsoi, Ma et al. 2009). Of the 1,498 studies they have identified 
through database searches, the discussion was based in the review of three randomized, 
controlled trials (Lin, Wang et al. 1996; Lee, Turnipseed et al. 1999; Bjorkman, Zaman et 
al. 2004) and five retrospective cohort studies (Cooper, Chak et al. 1998; Cooper, Chak et 
al. 1999; Schacher, Lesbros-Pantoflickova et al. 2005; Tai, Huang et al. 2007; Targownik, 
Murthy et al. 2007). They found great heterogeneity in the study design, follow-up period, 
endoscopic therapy and adjuvant therapy in these eight studies. One crucial factor in the 
evaluation of timing for early endoscopy is whether hemodynamically unstable patients 
were excluded from the studies. Among the eight trials, two specifically excluded 
hemodynamically unstable patients (Lee, Turnipseed et al. 1999; Bjorkman, Zaman et al. 
2004). Five studies included both stable and unstable patients (Lin, Wang et al. 1996; 
Cooper, Chak et al. 1998; Cooper, Chak et al. 1999; Schacher, Lesbros-Pantoflickova et 
al. 2005; Tai, Huang et al. 2007) and one study included only hemodynamically unstable 
patients (Targownik, Murthy et al. 2007). They concluded that early endoscopy (less than 
2 to 6 h) showed no improvement in clinical outcomes compared with a delayed approach 
[less than 24 to 48 h] (Tsoi, Ma et al. 2009). This has also been reflected by a large 
prospective UK audit, that demonstrated that endoscopy within 12 h did not affect 
mortality or the need for surgery, but led to a decreased length of stay(Jairath, Kahan et 
al. 2012).  
 
Concluding, we need to focus on tools which address major concerns like effectiveness, 
safety and costs, in order to achieve, from medical, endoscopic, and pharmaceutical 
intervention, improvement in outcomes and reduce medical costs, by reducing rebleeding, 
length of hospital stay and the need for surgical procedures. We have already set out our 
view of these issues (Pedroto, Dinis-Ribeiro et al. 2012). 
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URGE
NORTHFigure 5: The North of Portugal and URGE localization
III RESEARCH METHODOLOGY 
 
IIIa. Setting 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
From January 2010 to December 2012, a prospective observational study was conducted 
at the endoscopy unit of Centro Hospitalar do Porto (CHP), a 820-bed acute care, 
university hospital, serving, as an out-of-hours endoscopy center, an estimated population 
of 3.7 million (one third of the national population), with about 38 percent of the national 
youth population concentrated in the region (figure 5). The northern region includes eight 
sub-regions and an area of about 21.278 km² (24% of the continent). Since October 2006, 
in CHP, 30 consultant trained gastroenterologists from eight hospitals and sixteen skilled 
assistant staff from the endoscopy unit [eight nurses and eight endoscopy technicians] 
were integrated as the emergency team, everyday from 8 pm to 8 am; they are 
responsible for handling all gastroenterology emergencies, especially those requiring 
urgent endoscopy. 
 
The objectives of the URGE are: to provide phone consultations during the night; to 
provide consultations on site and endoscopy. URGE receives around 800-1000 
patients/year, being around 53% of the patients acute upper bleeders; a non-variceal 
cause accounts for approximately 52% of these. Each institution is accountable for the 
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remuneration for out-of-hours gastroenterology physician work, except for the assistant 
staff [nurse and endoscopy technician] that is the sole responsibility of the endoscopy unit 
of CHP. In this way, all are allocating human and financial resources. CHP has eight 
emergency teams and quarterly, the head of the gastroenterology department from five 
hospitals, is responsible for sending to the URGE coordinator the physicians rota, 
according to the teams which have been assigned to them; physicians from the smaller 
units strengthen some teams; this reflects 1 shift/physician/month. The provision of 
emergency endoscopy fulfills all the recommendations of the British Society of 
Gastroenterology. CHP has elective beds for bleeders in  the acute medical or surgery 
units and two intensive care units. 
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III RESEARCH METHODOLOGY 
 
IIIb. The Process 
 
After the patient‘s arrival at the ED, they are taken care of firstly by ED staff; after the first-
steps in the patient‘s care, the gastroenterologist is called and the emergency upper 
endoscopy (EGD) is performed by the gastroenterology staff. Referral patients are 
stabilized in the nearest hospital and transferred after agreement with the consultant 
gastroenterologist. When appropriate and safe, the procedure takes place in the 
endoscopy unit or in the emergency room or theatre. The decision to, where and when to 
perform EGD, diagnostic or therapeutic, is decided by the individual endoscopist, although 
he is guided by a regional protocol, which defines the need for therapeutic endoscopy 
according to international consensus statements (Barkun, Bardou et al. 2010; Laine and 
Jensen 2012). The endoscopist determines the level of anesthetic support. After the 
procedure, the patients are admitted or transferred back to their institution. Our practice is 
to perform EGD before discharge on all patients who have AUGIB and then, decide to, 
admit, discharge or transfer. In order to identify whether interventions might improve 
quality of care, the authors prospectively collected data, to investigate the outcomes of 
these patients and correlate them to the all process of care. We took several important 
steps: the first retrospective clinical audit, twelve months after the model's implementation, 
demonstrated weak adherence to important aspects of care and highlighted the areas that 
required improvement. In 2010, clinical guidelines, including safe transfer practice, for 
AUGIB were implemented and spread among all the northern institutions, whatever their 
level of care. They were reviewed and approved by the directors of all gastroenterology 
departments and published (I Pedroto and F Magro. Gestão Clínica da Hemorragia 
Digestiva Alta: Normas de Orientação Clínica. Conselho Diretivo da ARS-Norte, 2010-see 
appendix). Also, check sheets have been updated; the pilot test showed that the first was 
too long, with a large number of items;  now a simple check sheet, that separates the 
process into sub steps, is fulfilled for all the bleeding patients: time of contact, time of 
arrival, hemodynamics, risk stratification, medication, time of endoscopy, time of 
discharge; nurses do part of this job. Data are filled out by the attending physician; nurses 
do part of this job (figure 6). In fact, the availability of appropriately trained and 
experienced endoscopy nursing support (a fixed team from the endoscopy unit of CHP) is 
an aspect of key importance. URGE receives around 800 patients/year, being  53% of the 
patients acute upper bleeders; 52% of these, bleed from a non-variceal cause. In northern 
Portugal, until October 2006,  the out-of-hours management of AUGIB was dependent on 
the organizational structure of the each hospital, with great variability (8am-8pm every 
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day, no weekends, or 8am-24pm weekdays or 8am-24pm weekdays and weekend). The 
URGES' coordinator is responsible for checking the standardized-item list. The complete 
30 days follow-up was ensured by analysis of the electronic database or by direct 
telephone contact. All the data are used to fulfill a framework for NVAUGIB, adapted from 
the British Society of Gastroenterology (tables 6 and 7). 
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Evaluation Question 
 
Dataset Analysis 
How many NVAUGIB 
patients? 
Patients with NVAUGIB Number of patients presenting in 
the evaluation period 
Where do patients come 
from? 
Source of referral: 
Local or inter-hospital 
transfer 
Number and % of local vs. 
transfers 
Where patients transferred 
after local agreement? 
Time of referral (phone) 
Time of arrival to local 
service 
 
Number and % of patients 
transferred after previous 
agreement 
Mean transfer time 
Mean time to arrival 
When do patients present 
with NVAUGB? 
Data and time of 
presentation with NVAUGIB  
Distribution of times of 
presentation: 
 Year 
 Month 
 Day of the week 
 Time of the day 
 In-hours vs. out-of-hours 
 Weekday vs. weekend 
Are patients referred 
appropriately for endoscopy? 
 
Inappropriate referral: 
 not provided 
 no AUGIB 
If provided: 
 data and time 
 therapeutic 
intervention 
 inconclusive 
Number and % of patients who 
met criteria of AUGIB 
Distribution of times to endoscopy  
Number and % of therapeutic 
endoscopy 
What risk level presented the 
patients? 
 
 
Risk levels of patients with 
NVAUGIB  
Distribution of patients: 
 Low-risk 
 Moderate-risk 
 High-risk 
Adverse events: 
 during transfer 
 in-hospital 
 endoscopy 
Comorbidities 
Age 
Medication 
How were patients managed 
after endoscopy? 
Discharged 
Admitted as inpatients 
Inter-hospital transfer 
Distribution of patients: 
 Admission  
 Transferred 
 Discharged 
 
 
 
 
 
 
  
Table 6: NVAUGIB: An Evaluation Framework (January 2010-December 2012) 
 How was the service used? 
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Evaluation Question 
 
Dataset Analysis 
How many patients had 
endoscopy? 
Date and time of 
endoscopy 
Number and % of endoscopic 
procedures: 
 local 
 transfers 
 
Was endoscopy timely? Date and time of 
endoscopy 
Distribution of times to 
endoscopy : 
 local  
 transfers 
 
How many patients had 
therapeutic endoscopy? 
Date and time of 
endoscopy 
Number and % of endoscopic 
procedures: 
 local 
 transfers 
 
How many patients had to 
repeat endoscopy 
(inconclusive)? 
Patients with NVAUGIB Number and % of patients: 
 local 
 transfers 
  
How many patients 
rebled? 
Source of referral: 
Local or inter-hospital 
transfer 
Number and % of patients that 
rebled: 
 local  
 transfers  
How many patients had 
surgery? 
Date and time of 
procedure 
Indication for surgery 
Number and % of patients who 
received surgery: 
 local  
 transfers 
 
How many patients died 
from NVAUGIB? 
 
 
 
In-hospital mortality 
30 day mortality  
According to: 
 local  
 transfers 
How many patients died 
from other causes? 
 
Patients with NVAUGIB Cause of death 
 
 
 
 
 
  
Table 7: NVAUGIB: An Evaluation Framework (January 2010-December 2012) 
 How was the service provided? 
provided? 
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Figure 6 
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III RESEARCH METHODOLOGY 
 
IIIc. Patients and Data Analysis 
 
Data on all consecutive patients, aged 18 and over, admitted directly to the emergency 
department of Centro Hospitalar do Porto (ED-CHP) or transferred from another 
institution, were prospectively collected. Patients with a new onset of NVAUGIB [clinical 
evidence of overt upper bleeding on admission or a history of hematemesis, coffee ground 
vomiting, melena, hematochezia, or a combination of any of these within 24h preceding 
admission] and with an upper endoscopy performed were included. Patients were 
excluded if they were younger than 18 years old, if endoscopy was not performed, had 
chronic anemia or bled as inpatients hospitalized for an unrelated illness. Demographic, 
clinical and endoscopic data from patients with NVAUGIB were collected and those with 
other sources of bleeding were excluded. Comorbidity was defined as the presence of any 
of the following diseases: (1) cardiac disease including ischemic heart disease and 
congestive heart failure; (2) hypertension; (3) chronic liver disease; (4) chronic renal 
disease; (5) vascular disorders including peripheral and central vascular diseases; (6) 
history of stroke; (7) diabetes; (8) malignancy; (9) metastatic malignancy; (10) renal or 
liver transplant; (11) hereditary bleeding disorder; (12) peptic ulcer disease, complicated 
or not. All medication, at time of presentation, was recorded. Patient workflow was 
examined: time of admission at the first hospital, time of first contact to the endoscopy 
unit, time of arrival to the endoscopy unit, time of endoscopic procedure, time of inpatient 
admission, discharge or transferred back to the first hospital; endoscopic lesion and 
therapy; adverse events (table 8). Mortality was defined as any death occurring during 
hospitalization or within 30 days of the index bleeding episode and considered as bleeding 
related (after uncontrolled bleeding; occurring within 24h after endoscopy; during surgery 
for uncontrolled bleeding; adverse events during endoscopy or surgery) or non-bleeding 
related (comorbidity or nosocomial infections). Rebleeding was defined as recurrent 
haematemesis, melena, with hemodynamic instability or a decrease in hemoglobin 
concentration of at least 2g/L and confirmed by a second endoscopy, recurring within 30 
days.  
 
Our primary variables were out-of-hours direct admissions to ED-CHP vs. out-of-hours 
transferred patients from another institution. 
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Table 8: Baseline characteristics of patients and data recorded 
Symptoms / signs (hematemesis, melena, hematochezia) 
Age  
Gender 
Prior upper gastrointestinal clinical events (e.g., bleeding, perforation) 
Major current comorbidities 
Key medications (NSAIDs, antithrombotics, and antisecretory) 
Hemoglobin and hematocrit (at presentation) 
Platelets, INR, urea, creatinin 
Transfusions (number of units) 
Timing of endoscopy (hours after presentation to the first hospital: CHP or other hospital) 
Timing of first contact to the endoscopy tertiary referral regional endoscopy unit 
Timing of arrival to the endoscopy tertiary referral regional endoscopy unit 
Timing of admission or transfer or discharge, after endoscopy 
Endoscopic Lesion  
Stigmata of hemorrhage (Forrest classification) 
Endoscopic therapy 
Score from scoring system validated to predict outcomes (Rockall) 
In-hospital rebleeding 
30 day Readmissions 
Surgery 
30-day Mortality  
Exclusion Criteria 
Age under 18 years 
Symptoms or signs of blood loss or anemia 
Patients that did not undergo endoscopy for the following reasons: patients specifically 
categorized as terminal care patients; patients who refused or whose family refused to 
consent to endoscopy; patients self discharging prior to endoscopy being undertaken; 
patients requiring direct and urgent surgical intervention because of rapid exsanguination; 
patients with a specific contraindication to endoscopy; and patients who died rapidly on 
admission 
Bleeding in patients already hospitalized for unrelated disease 
Patients hospitalized in other clinics and presented just for endoscopy examination 
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III RESEARCH METHODOLOGY 
 
IIId. Statistical Analysis 
 
Categorical variables were described as absolute frequencies (n) and relative frequencies 
(%). Median and percentiles or median and standard deviation were used for continuous 
variables. When testing a hypothesis about categorical variables a chi-square test and 
Fisher‘s exact test were used, as appropriate. In order to have a more thorough 
understanding of the factors associated, with mortality (in-hospital and 30 day) and 
rebleeding, univariate and multivariate logistic regression modeling was used. Factors that 
were significant in the univariate analysis at p<0.2 were included in the multivariate logistic 
regression models. Variables that have been previously identified to carry important 
prognostic significance in patients with NVAUGIH were included in the final multivariate 
model even if they didn‘t meet statistical significance on univariate analysis. Model 
discriminative power was evaluated by receiver-operator curve (ROC) curve analysis with 
confidence interval 95% (CI95%). The significance level used was 0.05.  Statistical 
analysis was performed using the software Statistical Package for the Social Sciences v. 
20.0. 
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IV. RESULTS 
 
IVa. Overall Results  
  
Data were collected from January 2010 to December 2012. All consecutive patients who 
had an endoscopic diagnosis of NVAUGIB were enrolled: 680 patients (53.4% men) were 
referred for endoscopy after previous contact with the gastroenterologist who agreed to 
receive the patient. We excluded 43 patients who bled as inpatients. Our study involved 
368 patients who were directly admitted to the ED-CHP while 274 were transferred from 
other hospitals (figure 7). In CHP, similar to other hospitals, at admission, patients are 
managed by the emergency internists or surgeons. 
 
 
In the evaluation period, 642 patients with a mean age of 66 ±16,5 years (19-97 years) 
met the criteria of NVAUGIB: 65% of the patients were male and 35%, female. Patients 
were divided according to age groups as in the Rockall risk stratification, the score used in 
this study: two thirds of the patients had 60 or more years and 24% had 80 or more years. 
 
 
680 patients screened with a diagnosis of NVAUGIB
Figure 7: Patient’s enrollment beyween January 2010-December 2012
ED-CHP
N= 368
Inter-Hospital Transfer
N= 274
Excluded: inpatients
N=4
Excluded: inpatients
N=34
ED-CHP 
In-hours: 8am-8pm
N= 255
ED-CHP
Out-of-hours: 8pm-8am
N=113
Inter-Hospital  Transfer
In-hours: 8am-8pm
N= 55
Inter-Hospital  Transfer
Out-of-hours: 8pm-8am
N=219
Included
N=642
This flow chart details the patient enrollment in the study.
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As regards the type of admission, 368 (57.3%) were direct admissions to the ED- CHP 
and 274 (42.7%) were transferred from other hospitals.  
 
The hospitals that most contributed to referrals are illustrated as a Pareto diagram in 
figure 8. 
 
 
0
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80
100
120
140
160
Nº Patients
Figure 8: Pareto diagram - referrers hospitals versus the number of 
patients
       
 Total 
N (%)  
 
ED-CHP 
N (%)  
8am-8pm 
 
N (%)  
8pm-8am 
Referrals 
N (%)  
8am-8pm 
 
N (%)  
8pm-8am 
p  
      0.128 
<60 
60-79 
>80 
Total 
214 (33.3) 
274 (42.7) 
154 (24.0) 
642 
73 (28.6) 
115 (45.1) 
67 (26.3) 
255  
32 (28.3) 
51 (45.1) 
30 (26.5) 
113  
23 (41.8) 
23 (41.8) 
9 (16.4) 
55  
86 (39.3) 
85 (38.8) 
48 (21.9) 
219  
 
       
Age (years) 
Table 9: Overall results: age groups vs. admission status. 
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It‘s worth mentioning that while there were referrals from 30 hospitals, 20% of them were 
responsible for 65% of the demand, the neighboring institutions. The importance of this 
flow of patients and hospital's contribution, is geographically demonstrated below in figure 
9. 
 
Figure 9: Geographic visualization: flow of patients and hospital's contribution. 
St.Maria Feira
The diameter of the circle is 
proportional to the number of 
transferred patients
Tâmega e Sousa
Porto-HSJ
Matosinhos
Vila Real
Famalicão
V.N.Gaia
URGE
Póvoa do Varzim
Lamego
Bragança
Chaves
Braga
Guimarães
St.Tirso
Barcelos
Viana Castelo
Valongo
 
 
 
The first step in improving the emergency process is to collect the necessary data to 
understand patient's volume and flow. Timeliness of care can influence the outcome and 
is an important consideration for patient safety, as well as one of the strongest predictors 
of patient satisfaction. In order to improve timeliness of care, we must first understand 
facility-specific utilization and patterns. 
 
Over the three years, the number of cases has decreased, both in local and in transfers, 
in in-hours and in out-of-hours. Nevertheless, they have remained proportionally 
distributed over the time periods and months, between the two groups, emergency and 
transferred (table 10).  
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Table 10: Overall results - the demand according to the year and month of the year vs. 
time and admission status. 
 
 
 Total 
N (%)  
 
ED-CHP 
N (%)  
8am-8pm 
 
N (%)  
8pm-8am 
Referrals 
N (%)  
8am-8pm 
 
N (%)  
8pm-8am 
p  
 
Year 
 
 
 
     
0.097 
2010 
2011 
2012 
Total 
316 (49.2) 
174 (27.1) 
152 (23.7) 
642 
119 (46.7) 
70 (27.5) 
66 (25.9) 
255 (39.7) 
48 (42.5) 
30 (26.5) 
35 (31.0) 
113 (17.6) 
28 (50.9) 
13 (23.6) 
14 (25.5) 
55 (8.6) 
121 (55.3) 
61 (27.9) 
37 (16.9) 
219 (34.1) 
 
 
 
Month 
 
      
0.187 
January 
February 
March 
April 
May 
June 
July 
August 
September 
October 
November 
December  
57 (8.9) 
61 (9.5) 
68 (10.6) 
57 (8.9) 
59 (9.2) 
64 (10.0) 
62 (9.7) 
51 (7.9) 
44 (6.9) 
39 (6.1) 
53 (8.3) 
27 (4.2) 
22 (8.7) 
29 (11.4) 
25 (9.8) 
20 (7.8) 
20 (7.8) 
28 (11.0) 
21 (8.2) 
14 (5.5) 
17(6.7) 
19 (7.5) 
29 (11.4) 
11 (4.3) 
9 (7.8) 
8 (7.1) 
6 (5.3) 
11 (9.7) 
11 (9.7) 
11 (9.7) 
9 (8.0) 
17 (15.0) 
12 (10.6) 
5 (4.4) 
8 (7.1) 
6 (5.3) 
6 (10.9) 
1 (1.8) 
7 (12.7) 
4 (7.3) 
8 (14.5) 
6 (10.9) 
7 (12.7) 
3 (5.5) 
2 (3.6) 
5 (9.1) 
5 (9.1) 
1 (1.8) 
20 (9.1) 
23 (10.5) 
30 (13.7) 
22 (10.0) 
20 (9.1) 
19 (8.7) 
25 (11.4) 
17 (7.8) 
13 (5.9) 
10 (4.6) 
11 (5.0) 
9 (4.1) 
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Concerns about determinants of resource demand have been raised and by taking this 
into account, we also examined changes in productivity in relation to the day of the week 
and weekday vs. weekend [8pm Friday to 8am Monday]. 
 
Direct in-hours admissions were less frequent on Sunday; half of the patients observed on 
Sunday in-hours, came from other hospitals; by contrast, Sunday and Wednesday nights, 
were the most busy, at the expense of transferred patients. Two thirds of the patients that 
were directly admitted in emergency, day or night, did it mostly during the week. On the 
contrary, patients transferred, day or night, showed a similar distribution, 54.5% and 
56.6%, in or out-of-hours, respectively. For NVAUGIB, the less busy day of the week was 
Thursday (table 11). 
 
When we assayed the service provision by weekday or weekend [from Friday 8pm to 
Monday 8am] we observe that transferred patients are homogeneous distributed, unlike 
the patients directly admitted to ED-CHP; this is obviously explained by the lack of 
provision of endoscopy in many hospitals at weekdays, after 2pm and at weekends. 
Transferred patients are responsible for 42% and 36% of the endoscopic procedures at 
weekends and weekdays, respectively.  
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Table 11: Overall results - the demand according to weekday and weekend vs. time and 
admission status. 
 
 
 
 
Patients are stabilized in the nearest hospital and transferred after agreement with the 
consultant gastroenterologist. This was accomplished in 68% of the cases, according to 
the standardized questionnaire, filled out by the attending physician or the assistant nurse.  
 
Of the 642 patients, 67% we admitted during the week and 33% during weekend. More 
patients were admitted after-hours (52%) compared with in-hours (48%). 
 
Procedures performed after-hours were further analyzed and we observed that 54% 
occurred between 12am and 8am. 
 
 Total 
N (%) 
 
ED-CHP 
N (%) 
8am-8pm 
 
N (%) 
8pm-8am 
Referrals 
N (%) 
8am-8pm 
 
N (%) 
8pm-8am 
p 
Day of the 
week 
     0,004 
Sunday 
Monday 
Tuesday 
Wednesday 
Thursday 
Friday 
Saturday 
87 (13.6) 
90 (14.0) 
87 (13.6) 
103 (16.0) 
74 (11.5) 
101 (15.7) 
100 (15.6) 
22 (8.6) 
40 (15.7) 
36 (14.1) 
42 (16.5) 
35 (13.7) 
46 (18.0) 
34 (13,3) 
10 (8.8) 
16 (14.2) 
21 (18.6) 
12 (10.6) 
17 (15.0) 
20 (17.7) 
17 (15.0) 
11 (20.0) 
9 (16.4) 
3 (5.5) 
7 (12.7) 
4 (7.3) 
7 (12.7) 
14 (25.5) 
44 (20.1) 
25 (11.4) 
27 (12.3) 
42 (19.2) 
18 (8.2) 
28 (12.8) 
35 (16.0) 
 
 
 
Weekday 
Weekend 
 
430 (67.0) 
212 (33.0) 
 
199 (78.0) 
56 (22.0) 
 
77 (68.1) 
36 (31.9) 
 
30 (54.5) 
25 (45.5) 
 
124 56.6) 
95 (43.4) 
 
0,000 
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The patient flow, lead time was examined as detailed in the next table: 
 
Table 12: Overall results -  Patient Flow: Lead Time. 
 
 
Lead time 
Median Time (hours) 
ED-CHP 
8am-8pm 
 
8pm-8am 
Referrals 
8am-8pm 
 
8pm-8am 
P 
 
 
From first ED to ED-
CHP 
 
  15.0 6.8 0.003 
Weekday   16.1 6.5 0.013 
Weekend 
 
  11.5 7.7 0.302 
From first ED to 
endoscopy 
 
4.32 6.0 14.7 7.7 0.009 
Weekday 7.8 8.8 11.5 8.8 0.130 
Weekend 7.9 5.4 9.5 8.3 0.178 
 
 
  
 
As noticed in table 12, time to arrival to ED-CHP was significantly higher during the day 
compared with the night (15h vs. 7h, p=0.003). 
 
Patients transferred during daytime had a significantly longer time to endoscopy 
compared with patients admitted during the night (15h vs. 7h, p=0.009). 
 
Patients were predominantly men (67%) with 24% of them with 80 years old or more and 
similar between groups. The characteristics of the patients are outlined in table 12, 
according to time and status of admission. Patients' age are not significantly different 
among the four groups. Patients admitted out-of-hours presented more often with 
haematemesis (72% and 74% vs. 45% and 56% respectively, p<0.000). Comorbidities 
were not significantly different among the four groups, but patients admitted to ED-CHP, 
/ Chapter IV - Results 
 
140 
during the day, tended to be more often known with metastatic malignancy and vascular 
disease (p=0.05 and p<0.05). Patients characteristics are detailed in table 13. 
 
 
       
       
       
 Total 
N (%) 
 
ED-CHP 
N (%) 
8am-8pm 
 
N (%) 
8pm-8am 
Referrals 
N (%) 
8am-8pm 
 
N (%) 
8pm-8am 
p  
Sex 
Male 
Female 
 
 
430 (67) 
212 (33) 
 
166 (65) 
89 (35) 
 
74 (66) 
39 (34) 
 
20 (36) 
35 (64) 
 
64 (29) 
155 (71) 
0.527 
Age (years) 
< 60 
>60 - <80 
≥80 
 
 
214 (33.3) 
274 (42.7) 
154 (24.0) 
 
73 (28.6) 
115 (45.1) 
67 (26.3) 
 
32 (28.3) 
51 (45.1) 
30 (26.5) 
 
23 (41.8) 
23 (41.8) 
9 (16.4) 
 
86 (39.3) 
85 (38.8) 
48 (21.9) 
0.128 
Clinical presentation 
Hematemesis 
Melena 
Hematochezia 
 
 
374 (58.9) 
320 (50.4) 
41 (6.5) 
 
116 (45.7) 
133 (52.4) 
13 (5.1) 
 
73 (74.6) 
46 (40.7) 
9 (8.0) 
 
31 (56.4) 
36 (65.5) 
4 (7.3) 
 
154 (72.3) 
105 (49.3) 
15 (7.0) 
 
0.000 
0.021 
0.715 
Comorbidities 
(N=638) 
Cardiac disease 
Chronic renal 
disease 
Blood disorders 
Chronic liver 
disease 
Vascular disease  
Previous stroke 
Peptic ulcer disease 
 
 
84 (32.9) 
70 (11.0) 
 
11 (1.7) 
78 (12.2) 
 
63 (9.9) 
63 (9.9) 
84 (13.2) 
 
 
38 (33,6) 
35 (13,7) 
 
3 (1,2) 
30 (11,8) 
 
37 (14,5) 
27 (10,6) 
32 (12,5) 
 
 
13 (23.6) 
15 (13.3) 
 
5 (4.4) 
16 (14.2) 
 
12 (10.6) 
9 (8.0) 
22 (19.5) 
 
 
38 (33.6) 
5 (9.1) 
 
2 (3.6) 
10 (18.2) 
 
3 (5.5) 
2 (3.6) 
3 (5.5) 
 
 
55 (25.6) 
15 (7.0) 
 
1 (0.5) 
16 (14.2) 
 
11 (5.1) 
25 (11.6) 
27 (12.6) 
 
 
0.185 
0.098 
 
0.037 
0.383 
 
0.005 
0.289 
0.074 
Table 13: Overall results -  Patients characteristics for NVAUGIB and in sub-groups 
according to time and admission status. 
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complicated or not 
Hypertension 
Diabetes 
Malignancy 
Metastatic 
malignancy 
Renal or liver 
Transplanted 
 
291 (45.6) 
149 (23.4) 
81 (12.7) 
20 (3.1) 
 
11 (1.7) 
 
125 (49.0) 
68 (26.7) 
41 (16.1) 
14 (5.5) 
 
8 (3.1) 
 
43 (38.1) 
26 (23.0) 
16 (14.2) 
2 (1.8) 
 
2 (1.8) 
 
 
27 (49.1) 
9 (16.4) 
6 (10.9) 
1 (1.8) 
 
1 (1.8) 
 
 
96 (44.7) 
46 (21.4) 
16 (14.2) 
3 (1.4) 
 
0 (0.0) 
 
0.246 
0.317 
0.084 
0.050 
 
0.079 
Nº of comorbidities 
None 
1 
2 
≥ 3 
 
 
130 (20.4) 
177 (27.7) 
154 (24.1) 
177 (27.7) 
 
41 (16.1) 
63 (24.7) 
65 (25.5) 
86 (33.7) 
 
25 (22.1) 
29 (25.7) 
21 (18.6) 
38 (33.6) 
 
14 (25.5) 
19 (34.5) 
10 (18.2) 
12 (21.8) 
 
50 (23.3) 
66 (30.7) 
58 (27.0) 
41 (19.1) 
 
0.012 
Medication 
Anticoagulation at 
presentation 
Aspirin intake 
AAS 100 
AAS 150 
Clopidogrel 
NSAID use 
Anticoagulation + 
Aspirin + clopidogrel 
Aspirin + 
Clopidogrel 
 
350 (55.2) 
73 (11.4) 
 
 
95 (15.1) 
95 (15.1) 
77 (12.2) 
129 (20.4) 
6 (0.9) 
 
30 (4.7) 
139 (54.7) 
34 (13.3) 
 
 
39 (15.4) 
35 (13.8) 
26 (10.2) 
49 (19.3) 
4 (1.6) 
 
11 (4.3) 
53 (53.1) 
11 (9.7) 
 
 
18 (15.9) 
10 (8.8) 
18 (15.9) 
19 (16.8) 
1 (0.9) 
 
8 (7.1) 
31 (56.4) 
3 (3.6) 
 
 
5 (9.6) 
7 (13.5) 
2 (3.7) 
15 (28.3) 
0 (0.0) 
 
0 (0.0) 
120 (56.6) 
26 (11.9) 
 
 
33 (15.6) 
25 (11.8) 
19 (9.0) 
46 (21.7) 
1 (0.5) 
 
8 (7.1) 
0.342 
0.204 
 
 
0.718 
0.591 
0.077 
0.342 
0.538 
 
0.231 
PPI before 
endoscopy  
N=602 
 
467  
(77.6) 
186 
(75.6) 
89 
(79.5) 
37 
(75.5) 
155 
(79,5) 
0.728 
Clinical Rockall 
score  
 
 
 
 
 
 
 
 
 
 
0.150 
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Low risk ≤ 2 
Moderate risk 3-4 
High risk >4 
 
Low risk ≤ 2 
Moderate / High risk 
≥3 
 
 
283 (44.7) 
254 (40.1) 
96 (15.2) 
 
283 (44.7) 
350 (55.3) 
 
105 (41.2) 
113 (44.3) 
37 (14.5) 
 
105 (41.2) 
150 (58.8) 
 
50 (44.2) 
39 (34.5) 
24 (21.2) 
 
50 (44.2) 
63 (55.8) 
 
29 (53.7) 
16 (29.6) 
9 (16.7) 
 
29 (53.7) 
25 (46.3) 
 
99 (46.9) 
86 (40.8) 
26 (12.3) 
 
99 (46.9) 
112 (53.1) 
 
 
 
 
 
0.323 
Complete Rockall 
score 
(N=627) 
Low risk ≤ 2 
Moderate risk 3-4 
High risk >4 
 
 
 
 
71 (11.3) 
192 (30.6) 
364 (58.1) 
 
 
 
35 (13.8) 
73 (28.7) 
146 (57.5) 
 
 
 
7(6.2) 
28 (25.0) 
77 (68.8) 
 
 
 
7 (13.2) 
19 (35.8) 
27 (50.9) 
 
 
 
22 (10.6) 
72(34.6) 
114 (54.8) 
0.115 
Low risk ≤ 2 
Moderate /High risk 
≥3 
 
71 (11.3) 
556 (88.7) 
35 (13.8) 
219 (86.2) 
7(6.2) 
105 (93.8) 
7(13.2) 
46(86.8) 
22(10.6) 
186 (89.4) 
0.195 
Hemodynamics 
Stable 
Heart rate > 100 
beats/min  
Systolic blood 
pressure  
< 100mmHg 
Systolic blood 
pressure ±SD, 
mmHg 
Diastolic blood 
pressure ±SD, 
mmHg 
 
350 (56.7) 
138 (22.4) 
 
129 (20.9) 
 
 
120±25 
 
 
66±14 
 
 
 
155 (62.2) 
49 (19.7) 
 
45 (18.1) 
 
 
122±25 
 
 
67±14 
 
 
 
63 (55.8) 
21 (18.6) 
 
29 (25.7) 
 
 
116±24 
 
 
62±14 
 
 
 
31 (57.4) 
15 (27.8) 
 
8 (14.9) 
 
 
125±27 
 
 
67±15 
 
 
 
101 (50.2) 
53 (26.4) 
 
47 (23.4) 
 
 
118±24 
 
 
65±14 
 
 
 
0.103 
0.103 
 
0.103 
 
 
0,024 
 
 
0.021 
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Heart rate ±SD 
beats/min  
Hemoglobin ±SD 
g/dL 
Hemoglobin ≤ 7 
g/dL 
Hemoglobin > 7 
g/dL 
92±20 
 
9,0±3,8 
 
175 (27.9) 
 
452 (72.1) 
 
88±19 
 
8,7±2,8 
 
75 (29.5) 
 
179 (70.5) 
91±23 
 
9,1±2,7 
 
29 (25.7) 
 
84 (74.3) 
94±23 
 
8,7±2,6 
 
22 (42.3) 
 
30 (57.7) 
92±20 
 
9,4±5,3 
 
49 (27.9) 
 
159 (76.4) 
0.001 
 
0.199 
 
0.047 
 
0.047 
 
 
  
EGD was performed in all patients, and 16.8% had to repeat the procedure, because of 
some limitations, namely blood, food or patient's intolerance, without sedation. The 
probability of repeating EGD was significantly higher in patients directly admitted to ED-
CHP. Just 6.8% of the patients were admitted in intensive care units; 15% were 
discharged and 56% were admitted as inpatients in CHP (figure 10). 
 
 
         
The first EGD was performed within 24h of presentation in 86% of the patients. Of the 
642, 290 (45%) required endoscopic therapy for hemostasis. Peptic ulcer was the main 
diagnosis (51%) being 52% gastric and 48% duodenal ulcers. Rebleeding was reported in 
8.9% and the 30-day mortality in this case cohort was 7.5% (46/615), being the bleeding 
episode responsible for 30% of the deaths. Significantly more patients endoscoped during 
0 50 100 150 200 250 300
ED-CHP 8am-8pm
ED-CHP 8pm-8am
Referrals 8am-8pm
Referrals 8pm-8am
Figure 10: Planning after EGD
Discharged
Transferred
Admitted as in-patients
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the night had surgery (p=0.015). The other outcomes were independent of the time or 
status of admission.  
 
      
 
 
 Total 
(%) 
 
ED-CHP 
(%) 
8am-8pm 
 
(%) 
8pm-8am 
Referrals 
(%) 
8am-8pm 
 
(%) 
8pm-8am 
p 
Rebleeding 8.9 8.3 11.6 6.4 8.7 0.687 
Surgery 4.1 1.6 8.0 1.9 5.8 0.015 
In- hospital 
mortality 
6 6 6 7 5.1 0.326 
30 day mortality 7.5 7.1 8.9 10 6.5 0.774 
 
No adverse events were reported during transfer but during the procedure: one sentinel 
event (death after cardio respiratory arrest) and four severe (one perforation after 
therapeutic endoscopy and three aspiration pneumonias); transient tachycardia, 
hypoxemia or self-limited bleeding were recorded as minor incidents.  
 
The median length of hospital stay was 6 days for both admission status groups.  
 
Table 14: Overall results - Patients outcomes for NVAUGIB and in sub-groups according 
to time and admission status. 
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IV. RESULTS 
 
IVb. Main Results 
 
The main results of this study are in the third paper that assesses the organization model 
of out-of-hours endoscopy by comparing two groups of patients, transferred vs. non-
transferred.  
 
The paper reinforces that NVAUGIB management requires the coordination of physicians, 
non-physician staff, rooms and equipment and can be described as a multi-step process 
for transferred patients: (1) admission to first ED; (2) clinical assessment and stabilization; 
(3) contact with the gastroenterologist of ED-CHP; (4) transfer; (5) admission to ED-CHP; 
(6) revision of patient's clinical condition; (7) endoscopic procedure; (8) planning after 
endoscopy; (9) transfer; (10) post-endoscopy management (figure 11). 
 
Figure 11: Patient workflow described as a multi-step process: visualizing the patient's 
journey.  
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Out-of-Hours Endoscopy for Non-Variceal Upper Gastrointestinal Bleeding 
 
 
Background: Most countries lack a well-coordinated approach to out-of-hours 
endoscopy. Economic constraints and lack of resources have been identified as 
important barriers. 
Objective: To assess the performance evaluation of an out-of-hours emergency 
endoscopy model of care. 
Design: During a 3 year period (January 2010 to December 2012), data from  
consecutive outpatients (n=332) with non-variceal acute upper gastrointestinal 
bleeding (NVAUGIB) admitted or transferred to a single referral  hospital were 
prospectively collected. 
Results: 34 % (n=113) were direct admissions whereas 66% (n=219) were 
transferred from other hospitals. Median time to upper endoscopy (EGD) was 6h 
and 7.7h for direct admissions and transferred respectively. EGD was performed 
within 24h in 90% of the patients. Rebleeding, in-hospital mortality, 30 day 
mortality and need for surgery were respectively 9.8%, 5.8%, 7.4% and 6.6% and 
were not significantly different between the two groups. Age, malignancy and 
moderate to high clinical Rockall risk score were independent predictors of in-
hospital mortality in both groups. Age remained as an important predictor of main 
outcomes in transferred patients, while comorbidities differed according to 
admission status and predictable outcomes. 
Conclusions: This gastroenterology emergency model improved access and 
equity to out-of-hours endoscopy in an effective, safety and timely way, recognized 
by the rates and the homogeneity observed in the outcomes, between transferred 
patients and direct admissions.  
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Introduction: Acute upper gastrointestinal bleeding (AUGIB) is the commonest 
cause of acute hospital admission to gastroenterology and therefore has a large 
impact on the acute medical admission workload. Changes in management have 
been shown in randomized controlled trials to improve outcome from AUGIB, but 
large observational studies of mortality trends following upper gastrointestinal 
hemorrhage reported no improvement in overall mortality over the last 2 decades 
(Rockall, Logan et al. 1995; van Leerdam, Vreeburg et al. 2003). The mortality 
associated to non-variceal acute upper gastrointestinal bleeding (NVAUGIB) 
remains significant, despite the therapeutic advances (Lanas, Perez-Aisa et al. 
2005; Leontiadis, Sharma et al. 2005; Lanas, Garcia-Rodriguez et al. 2009; Sung, 
Barkun et al. 2009; Sung, Tsoi et al. 2010). It is important to notice that differences 
in practice may be hampering comparisons between countries. Even in the same 
country, variability in patient's management is observed (Hearnshaw, Logan et al. 
2010; Muthiah, Enns et al. 2012). In this respect, NVAUGIB despite being an 
important reason for acute admission, the outcomes of patients who have 
experienced a NVAUGIB are poorly understood as a function of the all process of 
care (Pedroto, Amaro et al. 2013). Regionalization improves patient outcomes 
through two primary mechanisms: improved outcomes at high-volume, high-
specialty centers, and improved coordination of care within a given geographic 
area. The latter was the model adopted in northern Portugal. In October 2006, a 
regional emergency endoscopic out-of-hours center with different specialists from 
8 public institutions, at the same physical location, in the out-of-hours period, was 
set up. We thought that this model might offer high availability and quality at every 
stage, as well as continuity between each step of an interconnected treatment 
process, that would reduce the patient‘s waiting time for endoscopy, speed up 
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recovery with a multi-disciplinary approach, and manage resources in a more 
efficient way. Therefore we aimed at assessing the model performance by getting 
better insight into its effect on outcomes.  
 
Methods 
Patients selection: Data on all consecutive patients, aged 18 and over, admitted 
directly to the emergency department of Centro Hospitalar do Porto (ED-CHP) or 
transferred from another institution, were prospectively collected. As we have 
decided, at this stage, to focus on specific causes of bleeding so that current 
management strategies and prognosis could be put into adequate context, only 
patients who performed an upper endoscopy confirming a new onset of NVAUGIB 
(clinical evidence of overt upper bleeding on admission or a history of 
hematemesis, coffee ground vomiting, melena, hematochezia, or a combination of 
any of these within 24h preceding admission) were included. Patients were also 
excluded if they were younger than 18 years old, if endoscopy was not performed, 
had chronic anemia or bled as inpatients hospitalized for an unrelated illness. 
Demographic, clinical and endoscopic data from patients with NVAUGIB were 
collected. Comorbidity was defined as the presence of any of the following 
diseases: (1) cardiac disease including ischemic heart disease and congestive 
heart failure; (2) hypertension; (3) chronic liver disease; (4) chronic renal disease; 
(5) vascular disorders including peripheral and central vascular diseases; (6) 
history of stroke; (7) diabetes; (8) malignancy; (9) metastatic malignancy; (10) 
renal or liver transplant; (11) hereditary bleeding disorder; (12) peptic ulcer 
disease, complicated or not. All medication, at time of presentation, was recorded. 
Patient workflow was examined: time of admission at the first hospital, time of first 
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contact to the endoscopy unit, time of arrival to the endoscopy unit, time of 
endoscopic procedure, time of inpatient admission, discharge or transferred back 
to the first hospital; endoscopic lesion and therapy; adverse events. Mortality was 
defined as any death occurring during hospitalization or within 30 days of the index 
bleeding episode and considered as bleeding related (after uncontrolled bleeding; 
occurring within 24h after endoscopy; during surgery for uncontrolled bleeding; 
adverse events during endoscopy or surgery) or non-bleeding related (comorbidity 
or nosocomial infections). Rebleeding was defined as recurrent haematemesis, 
melena, with hemodynamic instability or a decrease in hemoglobin concentration 
of at least 2g/L and confirmed by a second endoscopy, recurring within 30 days.  
 
Model of Care 
Site, staff and capacity: From January 2010 to December 2012, a prospective 
observational study was conducted at the endoscopy unit of CHP, a 820-bed 
acute care teaching hospital serving, as an out-of-hours endoscopy center, an 
estimated population of 3.7 million (one third of the national population), with about 
38 percent of the national youth population concentrated in the region. The 
northern region includes eight sub-regions and an area of about 21.278 km² (24% 
of the continent). Since October 2006, in CHP, 30 consultant trained 
gastroenterologists from eight hospitals and sixteen skilled assistant staff from the 
endoscopy unit (eight nurses and eight endoscopy technicians) were integrated as 
the emergency team, everyday from 8 pm to 8 am; they are responsible for 
handling all gastroenterology emergencies, especially those requiring urgent 
endoscopy. The objectives of the Urgência Regional de Gastroenterologia (URGE) 
are: to provide phone consultations during the night; to provide consultations on 
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site and endoscopy. URGE receives around 800-1000 patients/year, being  
around 53% of the patients acute upper bleeders; a non-variceal cause accounts 
for approximately 52% of these. Each institution is accountable for the 
remuneration for out-of-hours gastroenterology physician work, except for the 
assistant staff (nurse and endoscopy technician) that is the sole responsibility of 
the endoscopy unit of CHP. In this way, all are allocating human and financial 
resources. CHP has eight emergency teams and quarterly, the head of the 
gastroenterology department from five hospitals, is responsible for sending to the 
URGE coordinator the physicians rota, according to the teams which have been 
assigned to them; physicians from the smaller units strengthen some teams; this 
reflects 1 shift/physician/month. The provision of emergency endoscopy fulfills all 
the recommendations of the British Society of Gastroenterology. CHP has elective 
beds for bleeders in  the acute medical or surgery units and two intensive care 
units. 
 
The Process: After the patient‘s arrival at the emergency department (ED), they 
are taken care of firstly by ED staff; after the first-steps in the patient‘s care, the 
gastroenterologist is called and the emergency GI upper endoscopy (EGD) is 
performed by the gastroenterology staff. Referral patients are stabilized in the 
nearest hospital and transferred after agreement with the consultant 
gastroenterologist. When appropriate and safe, the procedure takes place in the 
endoscopy unit or in the emergency room or theatre. The decision to, where and 
when to perform EGD, diagnostic or therapeutic, is decided by the individual 
endoscopist, although he is guided by a regional protocol, which defines the need 
for therapeutic endoscopy according to international consensus 
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statements(Barkun, Bardou et al. 2010; Laine and Jensen 2012). The endoscopist 
determines the level of anesthetic support. After the procedure, the patients are 
admitted or transferred back to their institution. Our practice is to perform EGD 
before discharge on all patients who have AUGIB and then, decide to, admit, 
discharge or transfer. In order to identify whether interventions might improve 
quality of care, the authors prospectively collected data, to investigate the 
outcomes of these patients and correlate them to the all process of care. We took 
several important steps: the first retrospective clinical audit, twelve months after 
the model's implementation, demonstrated weak adherence to important aspects 
of care and highlighted the areas that required improvement. In 2010, clinical 
guidelines, including safe transfer practice, for AUGIB were implemented and 
spread among all the northern institutions, whatever their level of care. They were 
reviewed and approved by the directors of all gastroenterology departments and 
published (I Pedroto and F Magro. Gestão Clínica da Hemorragia Digestiva Alta: 
Normas de Orientação Clínica. Conselho Diretivo da ARS-Norte, 2010). Also, 
check sheets have been updated; the pilot test showed that the first was too long, 
with a large number of items;  now a simple check sheet, that separates the 
process into sub steps, is fulfilled for all the bleeding patients: time of contact, time 
of arrival, hemodynamics, risk stratification, medication, time of endoscopy, time of 
discharge; nurses do part of this job. Data are filled out by the attending physician. 
The URGES' coordinator is responsible for checking the standardized-item list. 
The complete 30 days follow-up was ensured by analysis of the electronic 
database or by direct telephone contact. 
Outcomes: The main outcomes and quality measures were: time to endoscopy, 
rebleeding, surgical intervention and mortality, length of hospital stay, safety, 
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timeliness, equity and efficiency. Our primary variables was the admission status, 
direct admission to ED-CHP or transferred from another institution. 
 
 
Statistical analysis: Categorical variables were described as absolute 
frequencies (n) and relative frequencies (%). Median and percentiles or median 
and standard deviation were used for continuous variables. When testing a 
hypothesis about categorical variables a chi-square test and Fisher‘s exact test 
were used, as appropriate. In order to have a more thorough understanding of the 
factors associated, with mortality (in-hospital and 30 day) and rebleeding, 
univariate and multivariate logistic regression modeling was used. Factors that 
were significant in the univariate analysis at p<0.2 were included in the multivariate 
logistic regression models. Variables that have been previously identified to carry 
important prognostic significance in patients with NVAUGIB were included in the 
final multivariate model even if they didn‘t meet statistical significance on 
univariate analysis. Model discriminative power was evaluated by receiver-
operator curve (ROC) curve analysis with confidence interval 95% (CI95%). The 
significance level used was 0.05.  Statistical analysis was performed using the 
software Statistical Package for the Social Sciences v. 20.0. 
 
Ethics approval 
The study was approved by the Ethics Committee of Centro Hospitalar do Porto. 
Patient consent was obtained according to local regulations. 
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Results:  
The patients: between January-2010 and December-2012, all consecutive patients 
who had an out-of-hours endoscopic diagnosis of NVAUGIB were identified. We 
enrolled 332 patients with a mean age of 65±16 years (23-97) with a significantly 
higher proportion of men (69% vs. 31%); about two thirds of the patients had 60 or 
more years and 27% had 80 or more years. There were no differences in 
hemodynamics at presentation in first ED admission, nor in laboratory test results 
(such as hemoglobin). The admission Rockall risk score identified 44% and 47% 
as low-risk patients and the remaining 56% and 53% as moderate to high risk. The 
complete score categorized 9%, 31% and 60% of the patients as low, moderate 
and high risk respectively. The detailed patients characteristics are shown in table 
1. 
The process: as regards the type of admission, 113 (34%) were admissions to the 
ED-CHP and 219 (66%) were transferred from other hospitals. It‘s worth 
mentioning that while there were referrals from 30 hospitals, 20% of them were 
responsible for 65% of the demand, the neighboring institutions. Median time from 
admission to first hospital and arrival to CHP was 6.8h. The patient flow, lead-time, 
is illustrated in table 2. EGD had no limitations in 60.5% of the cases. The global 
major endoscopic findings were: peptic ulcer 56% (55% gastric ulcers; 45% of 
admissions and 62% of referrals) 88% with stigmata of active or recent bleeding 
defined according to the Forrest classification (FIa 7%, FIb 15%, FIIa 35%, FIIb 
18%, FIIc 25%); Mallory-Weiss tear 14.8%, erosions 5.7%, esophagitis 4.5%, 
tumor 4.2%,  arteriovenous malformations and bleeding after endoscopic therapy 
(resection techniques) 3.9%; not determined in 1.5% of EGDs. Endoscopic 
therapy was performed in 56% of the patients and was combined in 77% of the 
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cases: injection and mechanical therapy (clips) 42%, injection 39% and injection 
and thermal therapy in 19%.  
The outcomes: EGD was performed within 24h in 90% of the patients and in less 
than 6h in 40% of these. The median number of units of blood transfused was two. 
Surgery was carry out in those patients whose bleeding could not be stopped by 
primary endoscopic hemostasis or by a second endoscopic therapy, in 6.5% of the 
patients. No adverse events were reported during transfer but two during 
endoscopy, namely, aspiration pneumonia and respiratory arrest; transient 
tachycardia, hypoxemia or self-limited bleeding were recorded as minor incidents 
in 4 patients. Rebleeding occurred in 29 patients (29/295; 9.8%): 11.6% in direct 
admissions and 8.7% in transferred patients (p=0.423). In-hospital mortality was 
5.8% (18/311): 7.1% vs. 5.1% in direct admissions vs. referral patients (p=0.461). 
Thirty day mortality was also not significantly different between the two groups, 
7.4% (23/311), 8.9% for direct admissions and 6.5% for transferred patients (table 
3). Ongoing bleeding and rebleeding were the cause of death in 30% of the cases 
(20% in ED-CHP and 38% in transferred). The remaining 70% died from 
comorbidities and nosocomial infections. The median length of hospital stay was 6 
days for both groups (0-61 and 0-72 days for direct admissions vs. transfers). After 
EGD, 20% and 80% of the patients admitted directly to ED-CHP were discharged 
or admitted as inpatients; 71% of the referrals were transferred back to their first 
admission hospital and 27% stayed in CHP' units or ward, while 4% were 
discharged.  
After multivariate analysis only a few variables remained important in the 
prediction of rebleeding or mortality. The majority of rebleeding patients directly 
admitted to ED-CHP had a history of previous ulcer disease and a longer 
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timeframe to endoscopy (AUC=0.652 [0.476-0.829]). In the transferred group, 
patients with 80 years old or more showed a 11-fold significantly increased risk of 
rebleeding, than younger patients (AUC=0.753 [0.632-0.875]). Patients transferred 
with malignancy, a high risk clinical Rockall score and more than 80 years old 
presented a probability of 30-day mortality,  three, six and sixteen times greater 
(AUC=0.863 [0.775-0.951]). 
 
Discussion 
Despite the advent of endoscopic therapy, the accessibility of the patients to 
medical centers with experienced medical staff and adequate equipment is still 
limited in out-of-hours. The first step in improving the emergency process is to 
collect the necessary data to understand patient's volume, flow and outcomes. 
Timeliness of care can influence the outcome and is an important consideration for 
patient safety, as well as one of the strongest predictors of patient satisfaction. In 
order to improve timeliness of care, we must first understand facility-specific 
utilization and patterns. Comparisons of the present study with previous ones is 
difficult by the type of the population analyzed, direct admissions versus referrals 
from other institutions, once work in this area is scarce. 
Several implications can be drawn from this study: 
First, the organizational model: in this paper we present the results of NVAUGIB 
but many other emergencies need gastroenterological attention and all of them, 
and all patients (regardless of their geographical location) deserve a safe and 
effective care. The urgent gastroenterology service must not be addressed 
differently from others, like cardiology, pediatrics or trauma. Some reports have 
looked into some feasible options of emergency services configuration and others 
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have identified serious gaps in out-of-hours emergency endoscopy services 
(Hearnshaw, Logan et al. 2010). Our model has led to several benefits: first, an 
equal emphasis was placed on all patients from the northern region in terms of 
structure and process. Second, the participation of only consultant 
gastroenterologists, an experienced endoscopist nurse and an endoscopy 
technician that cleans and reprocesses the endoscopes, ensures safer care 
(Douglass, Bramble et al. 2005; da Silveira, Lam et al. 2006; Gibson, Hitchcock et 
al. 2006; Gyawali, Suri et al. 2007; Barkun 2010; Francisco José Martinez Cerezo 
2011; Heymann 2011; Jairath, Kahan et al. 2012; Muthiah, Enns et al. 2012; 
Cesaro, Kohn et al. 2013). Third, this model has led to a concentration of 
specialized work in a large hospital without compromising the emergency workload 
nor the physicians workday planning in their institutions; it must be understood as 
a fair distribution of duties instead of a duplicity of faint care in all or some 
hospitals. The increase in hours of activity is equitably distributed by the eight 
institutions, from Oporto district and one from Aveiro's district. Fourth, to avoid the 
ED-CHP overcrowding, transferred patients that don't require resuscitation or 
stabilization (most of them) by‐pass the emergency department and go directly to 
the endoscopy unit; on the other side, by having staff with the right skill, in the right 
place at the right time, the planning decision is taken in a timely manner for the 
patient after endoscopy. And in fact, 71% of the referrals were transferred back to 
the admission hospital, without creating greater demand bed (20 patients/year) nor 
theater constraints (4 patients/year); and 23% of direct admissions to ED-CHP 
were early discharged. Fifth, there was management widespread support for the 
new organization, with clinical guidelines disseminated and implemented 
appropriately as observed by clinical risk stratification in 98% of the patients, and 
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medication and comorbidities highlighted. These items are consistent with the 
study from Silveira and col., that emphasized the importance of the process of 
care (da Silveira, Lam et al. 2006). Sixth, although economic costs associated with 
admissions for patients with NVAUGIB are not available in Portugal, we can 
probably assume potential savings in hospitals where endoscopy is only available 
from Monday to 2pm Friday and in those with difficulties in endoscopy 
arrangements, even on weekdays. Our next step is to know our costs by mapping 
the patient's journey: ED admission; transfer; endoscopy session; costs/bed/day. 
However, the recent guidelines published by the National Institute of Clinical 
Excellence reported that units with more than 330 presentations of AUGIB per 
year are cost effective with an everyday service (2012); they didn't take into 
account the weekend, with probably more income, which is our case. So in our 
model, we have the structure, the volume and the process in place. In the near 
future, a cost effective analysis will be presented.  
Second, the relationship between service provision and outcomes. Our dependent 
variable was type of admission, direct admissions to ED-CHP vs. transferred 
patients. There was considerable homogeneity between groups: age, 
comorbidities, medication intake, risk stratification, baseline haemoglobin and 
hemodynamic at presentation. This translated to similar rates of outcomes which 
are consistent (Blatchford, Davidson et al. 1997; Hershcovici, Haklai et al. 2010) 
and even better (Rockall, Logan et al. 1995; van Leerdam, Vreeburg et al. 2003; 
Loperfido, Baldo et al. 2009)  than previous published population based studies. 
Moreover, the cause of bleeding was peptic ulcer in 56% of the cases, a rate 
slightly higher than in other published studies (Zimmerman, Meroz et al. 1994; 
Lanas, Aabakken et al. 2011; Villanueva, Colomo et al. 2013). So, by examining 
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the impact of out-of-hours endoscopy in patients with NVAUGIB we demonstrated 
the following: (1) 90% of the patients had an endoscopy performed in less than 
24h; (2) The transferred patients had a similar timeframe to endoscopy when 
compared to direct admissions; (3) The rates of rebleeding, in-hospital mortality 
and 30 day mortality were not significantly different according to the admission 
status; (4) Transferred patients with 80 or more years old were more likely to 
rebleed;  (5)  Clinical Rockall risk score predicted 30 day mortality in transferred 
patients unlike direct admissions where malignancy was the only strongest 
parameter; this may be particularly important in the decision to transfer, without 
delays; (6) The median length of hospital stay was 6 days for both groups, 
considered to be reasonable given the 60% of high risk patients and patient's age 
and comorbidities; (7) 71% of the referrals were transferred back, after endoscopy, 
to the first admission hospital; (8) we can always discuss whether we have done 
our part and whether it was enough. This relates mainly to post-endoscopic 
management, also a component of the all process of care. 
A strength of our study is that it demonstrates how a simple and safe model of 
care allows all NVAUGIB patients requiring urgent gastroenterologist care, 
regardless of where they live, to be cared for in the most appropriate setting in a 
timely and efficient manner. A limitation of our study is that it was not possible to 
determine the impact of the regionalization model on the economics of the 
hospitals that integrate the model, a work to be done in the near future. It also was 
not possible to determine this model cost-benefit and relative to other 
management strategies due to limited data avalailable on costs and efficacy. In 
this model, the importance of joining forces is undoubtedly demonstrated, has 
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already brought results, and enables available resources to be equitably 
distributed and accessible to the entire population of northern Portugal.  
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Tables and table legends 
Table 1 
Clinical and laboratory features of the study population according to admission status  
 
 Total 
N=332 
ED-CHP (N=113)  
 (%) 
Transferred (N=219) 
 (%) 
Male Gender 229 66 71 
Age (years) 
< 60 
>60 - <80 
≥80 
 
118 
136 
78 
 
28 
45 
27 
 
39 
39 
22 
Clinical presentation 
Hematemesis 
Melena 
Hematochezia 
 
227 
151 
 24 
 
75 
41 
8 
 
72 
49 
7 
Comorbidities  
Cardiac disease 
Chronic renal disease 
Blood disorders 
Chronic liver disease 
Vascular disease  
Previous stroke 
Peptic ulcer disease 
Hypertension 
Diabetes 
Malignancy 
Metastatic malignancy 
Renal or liver transplanted 
 
68 
30 
6 
32 
23 
34 
49 
139 
72 
32 
5 
2 
 
24 
13 
4 
14 
11 
8 
20 
38 
23 
14 
2 
2 
 
26 
7 
0,5 
14 
5 
12 
13 
45 
21 
14 
4 
0 
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Number of comorbidities 
None 
1 
2 
≥ 3 
 
75 
95 
79 
79 
 
22 
26 
19 
34 
 
23 
31 
27 
19 
Medication  
With medication 
Anticoagulation at presentation 
Aspirin intake 
AAS 100 
AAS 150 
Clopidogrel 
Aspirin + Clopidogrel 
Anticoagulation + Aspirin + 
Clopidogrel 
NSAIDs use 
 
145 
37 
 
95 
51 
35 
37 
16 
2 
65 
 
47 
10 
 
16 
16 
9 
16 
7 
1 
17 
 
43 
12 
 
15 
16 
12 
9 
7 
1 
22 
PPI before endoscopy  244 80 80 
Clinical Rockall score at first 
ED admission 
Low risk ≤ 2 
Moderate risk 3-4 
High risk >4 
Missing 
 
 
149 
125 
50 
8 
 
 
44 
35 
21 
 
 
47 
41 
12 
Complete Rockall score 
Low risk ≤ 2 
Moderate risk 3-4 
High risk >4 
 
30 
101 
194 
 
6 
25 
69 
 
11 
35 
55 
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Missing 11 
Hemodynamic at presentation 
(first ED admission) 
Normal 
Heart rate > 100 beats/min  
Systolic blood pressure  
< 100mmHg 
Systolic blood pressure ±SD, 
mmHg 
Diastolic blood pressure ±SD, 
mmHg 
Heart rate ±SD beats/min  
Hemoglobin ±SD g/dl 
 
 
164 
74 
76 
 
332 
 
332 
 
332 
332 
 
 
56 
19 
26 
 
116±24 
 
62±14 
 
91±23 
9.1±2.7 
 
 
50 
26 
24 
 
118±24 
 
65±14 
 
92±20 
9.4±5.3 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
SD, Standard deviation; NSAIDs, no steroidal anti-inflammatory drugs; PPI, proton 
pump inhibitors 
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Table 2 
 
Patient flow: Time to admission and time to endoscopy among patients directly admitted 
to CHP and those transferred 
 
 
 ED-CHP  
 
Transferred  
Median time of admission from first 
hospital to ED-CHP (hours) 
Weekday 
Weekend 
 
 
 
6.8 
 
6.5 
7.7 
Median time of admission from first ED 
to first endoscopy (hours) 
Weekday 
Weekend 
6.0 
 
4.7 
5.4 
7.7 
 
7.2 
8.3 
Time to endoscopy as admission from 
first ED to first endoscopy (%) 
≤6h 
>6h 
≤24h 
>24h 
 
 
46 
54 
88 
12 
 
 
38 
62 
91 
9 
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Table 3 
 
Main Outcomes according to admission status 
 
 
 
 
 
 
 
 
 
 
 
 ED-CHP  
 (%) 
Transferred 
 (%) 
Total 
(%) 
p  
Rebleeding 
 
11.6 8.7 9.8 0.423 
In-hospital mortality  
 
7 5 5.8 0.461 
30 day mortality  8.9 
 
4.2 7.4 
 
0.438 
Surgery  
 
7.9 5.8 6.5 0.454 
Median transfusion requirement 
(number of units) 
 
2 
(0-15) 
2 
(0-10) 
2 
(0-15) 
0.501 
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V. DISCUSSION 
 
This chapter starts with a discussion of the new organization regional model of care. A 
discussion on the implications for quality of care and the limitations follows. 
 
Paper III provides answers to the research questions about service performance. 
Structure and staff are an important requirement for being able to predict a safe and 
effective procedure because NVAUGIB is much more than an endoscopy. And outcomes 
are much more than numbers or rates. Donabedian (see chapter II) clarified that these 
categories should not be mistaken for attributes of quality, but rather they are the 
classifications for the types of information that can be obtained in order to infer whether 
the quality of care is poor, fair, or good. Outcomes are the result of the patient's interaction 
with the delivery health care system. 
 
Theorically, what are the strengths, weaknesses and pitfalls of our model of care? 
 
Strengths 
 
Regionalization of health care is a method of providing high-quality, cost-efficient health 
care to the largest number of patients. It implies the development of a structured system 
of care by directing patients to the right facilities and expertise. According to Menke TJ 
and Wray NP, the development of a regionalized system is typically driven by economic 
factors, such as the infeasibility of all hospitals to maintain the equipment and personnel 
to treat specific medical conditions, or by interhospital variations in patient outcomes 
within a geographic region (Menke and Wray 2001). And in fact, the resources that are 
needed for these patients, like staff, are in limited supply. Regionalization is a way to 
optimize the use of those limited resources, by delivering the right patient to the right 
hospital, at the right time. 
 
 Theoretically we could say that our model has advantages: 
 
1. Resources at CHP match the needs of the patients; 
2. Better coordination of care during the acute phase; 
3. Improved standardization of care within non-specialty hospitals; 
4. Improved provision of scarce services; 
5. NVAUGIB is a good example of an acute, time and expertise-dependent condition. 
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Weaknesses 
 
Patient and family satisfaction are quite important. Regionalization means that patients 
are more likely to receive care far from home which may be a source of dissatisfaction. 
Another significant challenge is managing quality at the system level, which is very 
different from managing quality at a single facility or a single service within a facility. Data 
collection requires that data elements be standardized and that many different sources of 
information come together to be shared bi-directionally.  
 
 Theoretically we could say that our model has disadvantages: 
 
1. Increased fixed costs and resources; 
2. Travel time costs to hospitals and families; 
3. Economic inefficiency if demand does not meet supply; 
4. The risk of transfer; 
5. Postdischarge follow-up care. 
 
Pitfalls 
 
An issue is associated with bypassing the closest hospital, without stabilization and 
preparation of a safe transfer. Another issue is the transfer of low risk patients or even 
non-bleeding patients, without previous communication, with misuse or overuse of 
resources.  
 
In practice, how was our model's performance? 
 
Research Question 1 
The care provided in NVAUGIB was accessible and timely? 
 
Most national and international guidelines recommend that EGD should be performed 
within 24h of presentation in patients with NVUAGIB (Palmer 2002; Barkun, Bardou et al. 
2003; Palmer and Nairn 2008; Barkun 2010). 
 
We did EGD to all patients directly admitted to ED-CHP or transferred from another 
hospital. Median time unit to out-of-hours endoscopy was 6h for direct admissions and 
7.7h for transferred patients. Ninety percent of the patients were endoscoped in the first 
24h. 
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On the other side, we analyzed the lead time for transferred patients, assuming time to 
endoscopy as the time from first ED admission to the endoscopy unit. This is issue is not 
mentioned in most of the studies by just referring to time as, time of admission in referral 
hospital, and others explicitly exclude transfer patients (Gralnek and Dulai 2004; 
Masaoka, Suzuki et al. 2007). Studies that mention the inclusion of patients transferred 
from another hospital didn´t analyze the outcomes in regard to the admission status 
(Phang, Vornik et al. 2000; Bjorkman, Zaman et al. 2004; Parente, Anderloni et al. 2005).  
 
Our model performed better than previous reports from other centers. Previous papers 
reported that the accessibility of the patients to medical centers with experienced medical 
staff and adequate equipment was still limited in out-of-hours (Douglass, Bramble et al. 
2005; Gibson, Hitchcock et al. 2006; Hearnshaw, Logan et al. 2010; Francisco José 
Martinez Cerezo 2011; Muthiah, Enns et al. 2012). The multi-centre cross sectional 
clinical audit performed in 2010 which involved over 75% of UK hospitals, collected data 
on 6750 patients (median age 68 years)  from 208 hospitals. Although 92% of facilities 
had out-of-hours endoscopy available, only half had an endoscopy on call rota that would 
ensure an endoscopist to be available if needed. Of those endoscoped only 50% had an 
endoscopy within 24 h of presentation. The median time from presentation to endoscopy 
was 23 h (see above, 6h for ED-CHP and 7.7h for transferred patients). Most patients 
(59%) presented out of hours with 20% presenting between midnight and 8 am but the 
majority (82%) of endoscopies were performed during normal working hours. In our 
cohort, 52% of the NVAUIB patients presented out-of-hours: 46% between midnight and 
4am; 41% between midnight and 4am and 13% from 4am to 8am. A percentage slightly 
different but explicable by the number of patients transferred, which inevitably arrived later 
at CHP. Another finding from this audit was that, as many as 42% of high risk patients 
(pre-endoscopy Rockall score >5) waited more than 24 h for their first endoscopy and 
14% waited more than 72 h. Ninety percent of our patients had an endoscopy in less than 
24h, whatever the admission status and risk stratification.  
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Research Question 2 
The care provided in NVAUGIB was appropriate and effective? 
 
Appropriateness is often treated as a single concept. However, there are two distinct 
types of appropriateness: appropriateness of a service and appropriateness of the setting 
in which care is provided. The differences between the two parallel the differences 
between two other concepts in health care: effectiveness and cost-effectiveness. 
 
Compared with non-transferred patients, patients transferred from other hospitals had 
similar outcomes, similar to those reported in the literature, single center studies or 
population based studies. To our knowledge, transferred patients are not included as a 
comparable group or are excluded from some studies, as mentioned above.  
 
An important issue of our study is that all patients with NVAUGIB, a part of risk 
stratification, had an endoscopy. This may be an area of some controversy. But the basic 
clauses are not in dispute and are supported by everyone: endoscopy is the most 
accurate and effective method for diagnosing the source of UGIB and treating most 
causes of NVAUGIB. Guidelines emphasize the importance of endoscopy within 24 h of 
presentation particularly for high risk patients (Barkun 2010). And 90% of our patients met 
this standard. 
 
We can always question if early endoscopy, defined as an endoscopy performed in the 
first 24h, translate into more effectiveness and efficiency; if we should discharge low-risk 
patients without an endoscopy or, on the contrary, if early endoscopy allows early 
discharge of low risk patients; in this case we must endoscope all patients. 
 
A systematic review of 23 studies analyzed the effectiveness of early vs. delayed 
endoscopy in low and high risk patients on patient and economic outcomes and 
concluded that early endoscopy is safe for all risk groups (Spiegel, Vakil et al. 2001).  A 
recent review aimed to evaluate the optimal timing of early endoscopy by examining the 
findings of randomized clinical trials and retrospective cohort studies that used 
comparable outcome measures and have been reported in the literature (Tsoi, Ma et al. 
2009). Of the 1,498 studies they have identified through database searches, 25 studies 
were selected for further scrutiny. They excluded 10 studies that focused on management 
of patients after early endoscopy and seven that did not report comparable outcome 
measures or only described management recommendations (Longstreth and Feitelberg 
1995; Hsu, Lai et al. 1996; Lai, Hui et al. 1997; Rockall, Logan et al. 1997; Yen, Hu et al. 
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1997; Longstreth and Feitelberg 1998; Cebollero-Santamaria, Smith et al. 1999; Almela, 
Benages et al. 2001; Cipolletta, Bianco et al. 2002; Brullet, Campo et al. 2004; Tammaro, 
Di Paolo et al. 2008). Therefore, the discussion was based in the review of three 
randomized, controlled trials and five retrospective cohort studies published between 1996 
and 2007(Lin, Wang et al. 1996; Cooper, Chak et al. 1998; Cooper, Chak et al. 1999; Lee, 
Turnipseed et al. 1999; Bjorkman, Zaman et al. 2004; Schacher, Lesbros-Pantoflickova et 
al. 2005; Tai, Huang et al. 2007; Targownik, Murthy et al. 2007). Interpretation of the 
results was limited by the heterogeneity of study designs: factors such as selection of 
patients, the use of different definitions of early endoscopy (which vary from 1 h to 48 h). 
Time to endoscopy was defined as the time since the patients were admitted to the 
emergency room or presented to hospital. Among the eight trials, two specifically 
excluded hemodynamically unstable patients (Lee, Turnipseed et al. 1999; Bjorkman, 
Zaman et al. 2004). Bjorkman and al. also excluded patients with severe comorbidities 
[Rockall score ≥6] (Bjorkman, Zaman et al. 2004). Targownik et al. just included 
hemodynamically unstable patients (Targownik, Murthy et al. 2007). Based on this review 
of eight studies, the authors concluded that early endoscopy may result in rapid 
hemostasis for high risk patients. In addition, early endoscopy may avoid hospitalization of 
low risk patients. A study has shown that early endoscopy significantly reduced rebleeding 
and surgery only in patients who required endoscopic hemostasis (Cooper, Chak et al. 
1999). It has been shown, however, that the length of hospital stay is reduced for all 
patients who undergo early endoscopy, compared with those who undergo routine 
endoscopy, regardless of their need for therapy. For some authors there is no doubt that 
appropriate endoscopic therapy significantly  reduces mortality, rebleeding, requirement 
for transfusion, hospital stay, and health-care costs (Cook, Guyatt et al. 1992). Of the 2 
studies that conducted a cost-analysis, both found significant savings from early 
endoscopy (Hay, Maldonado et al. 1997; Lee, Turnipseed et al. 1999). In the study from 
Lee and al. 46% of patients who presented to the emergency department  with AUGIB 
were discharged safely after endoscopic diagnosis and prognosis. Urgent endoscopy 
resulted in a 46% reduction in treatment costs and a 50% reduction in the length of 
hospital stay (Lee, Turnipseed et al. 1999). The value of preadmission endoscopy was 
realized only when the information obtained was used appropriately, namely, when low-
risk patients were discharged. A second, almost identical study of urgent endoscopy 
performed in the emergency setting showed opposite results, because the emergency 
department physicians refused to discharge low risk patients (Bjorkman, Zaman et al. 
2004).  
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In our case, if we have the support of physicians, nurses, equipment technicians and a 
well equipped facility, why should the procedure be delayed in high risk patients or why 
should low risk patients be discharged without the procedure? We can answer: it is time-
consuming; that´s truth, but: time is already being paid and the patients' time also has its 
costs, as labor or transportation. No patient experience information is presented, however 
we believe that all patients would like to be discharged after endoscopy and return home 
earlier. Twenty percent (low and moderate high risk) and 4% (low risk) of the patients 
directly admitted to ED-CHP and transferred respectively, were discharged. So we argue 
that early endoscopy allows early identification of high risk patients and high levels of care 
and provides the opportunity for early discharge. Nevertheless, cost-effectiveness 
analysis of early endoscopy may not be the answer (Pedroto, Dinis-Ribeiro et al. 2012). 
 
Research Question 3 
The care provided in NVAUGIB was supported by best evidence and practice guidelines? 
 
Recognized standards for these services include availability of endoscopically trained 
medical and nursing staff, access to a specialized endoscopy unit and full availability of 
the service. The procedure should only be done by consultant gastroenterologists with 
experienced endoscopic staff in the most appropriate setting, safeguarding and 
maximizing both, patient safety and procedure's effectiveness. Endoscopist's experience 
was also identified as an important prognostic factor for rebleeding and transfusion 
requirements in NVAUGIB, in a 2-year survey that prospectively assessed the impact of 
endoscopist's experience and time of endoscopy on the outcome; this study was 
conducted in a large tertiary referral center of western Milan, that also provides 24h 
emergency endoscopy for two district neighboring hospitals (Parente, Anderloni et al. 
2005). Also, previous work has suggested that early involvement of  endoscopists, such 
as that afforded by admission to the care of a dedicated in-patient gastroenterology 
service, can improve clinical and economic outcomes (Quirk, Barry et al. 1997). 
  
In our out-of-hours service all the requirements for a safe and effective procedure, 
capacity, equipment and staff, are in place. In CHP, 30 consultant trained 
gastroenterologists from eight hospitals and sixteen skilled assistant staff from the 
endoscopy unit (eight nurses and eight endoscopy technicians) integrate the after-hours 
emergency gastroenterology team and are responsible for handling all gastroenterology 
emergencies, and decide not only when and how to perform EGD but also the planning for 
the patient, after the procedure. 
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Experienced endoscopy nurses and endoscopy technicians, that clean and reprocess the 
endoscopes are part of the team. In UK, just 37% (76/205) of the facilities had a nurse 
(trained in the use of therapeutic endoscopic techniques) on call endoscopy rota. A survey 
of the practice of after-hours and emergency endoscopy in Canada concluded that more 
than one-third of surveyed endoscopists across the country didn't have a trained 
endoscopy nurse to assist in after-hours endoscopy and that significant regional 
differences in the practice of after-hours endoscopy were observed (Muthiah, Enns et al. 
2012). This is a quite disturbing finding as the need for appropriate technical assistance is 
more common during emergency procedures when haemostatic interventions are 
performed at a much higher rate than during the regularly scheduled procedures. But 
quality of care must be measured with continued and increased vigor. And clinical audit is 
a professionally way to participate in performance evaluation and a way to show 
accountability for quality of care. But clinical audit needs to be effective, by describing the 
exact improvement, select a strategy, design the change needed and operate the new 
way. This was not the case in UK. The two earlier surveys of the provision of out-of-hours 
endoscopy services in the UK (i.e., an on call rota of endoscopists) has not increased 
from the 50% reported by 150 hospitals in 2002 and the 49% reported in 2005(Douglass, 
Bramble et al. 2005; Gyawali, Suri et al. 2007). And in 2012, Jairath and al. published the 
results of a prospective audit that analyzed the outcomes of NVAUGIB in relation to time 
to endoscopy (Jairath, Kahan et al. 2012). Only 48% of endoscopies were performed 
within 24h and only 61% of the patients, classified with high risk stigmata of bleeding 
received therapeutic intervention. The emergency referral system was addressed in an 
Italian paper that concluded that in Lazio region, 30-day mortality rate from NVAUGIB, is 
lower when patients are admitted to EDs with greater resources (Cesaro, Kohn et al. 
2013). The authors suggested the need for a better organization of the emergency referral 
system because high risk were less frequently referred to better levels of care. In our 
cohort, this does not seem to be a problem since, 15% of the patients had a clinical 
Rockall risk score ≥ 4 and after endoscopy, 60% were high risk patients.  
 
If we analyze process indicators we met the standards in 80% to 90% of the cases with 
exceptions clearly defined which are much higher than those reported in other studies and 
in the clinical audits, mentioned above (table 15). 
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Table 15: Our Process Clinical Indicators 
 
Criteria Standard Quality Dimension Our Study 
% of patients who 
had an endoscopy in 
the first 24h 
 
Direct admissions 
Transferred 
 
100% Effectiveness 
 
 
 
Equity / 
Accessibility 
90% 
 
 
 
88% 
91% 
% of patients who 
had an admission 
Rockall score 
 
100% Effectiveness 100% 
% of patients who 
had acid suppression 
drugs before 
endoscopy  
 
100% 
(guidelines before July 
2012) 
Effectiveness 80% 
 
% of combined 
endoscopic treatment 
100%  
Exceptions 
 
Effectiveness 77% 
Exceptions: 
mechanical  
method 
% of adrenaline 
monotherapy 
0% Effectiveness 4% 
Exceptions: 
uncontrolled 
bleeding; clot not 
removed 
% of patients who 
repeated endoscopy 
when rebled  
 
100% 
Exceptions 
Effectiveness 100% 
% of patients referred 
urgently for surgery 
when rebled and 
instable 
100% 
Exceptions 
Effectiveness 100% 
 
 
 
 
 
 
 
Research Question 4 
The care provided in NVAUGIB was safe and efficient? 
 
In our study there is no evidence that early endoscopy resulted in patient's harm. 
Otherwise, it was a safe procedure: no adverse events were reported during transfer but 
two during endoscopy, namely, aspiration pneumonia and respiratory arrest; transient 
tachycardia, hypoxemia or self-limited bleeding were recorded as minor incidents in 4 
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patients. These rates are in agreement, even lower, than those reported in the current 
literature [<0.5%] (Ben-Menachem, Decker et al. 2012). 
 
Another safety issue concerns decontamination practices. A survey of the practice of 
after-hours endoscopy in Canada reported that, in provinces where endoscopy nurses 
were not available on-call, endoscopists and/or residents were directly responsible for 
endoscope cleaning and reprocessing (Muthiah, Enns et al. 2012). The authors also 
stated that the absence of trained specialized staff for endoscope cleaning and 
decontamination appeared to be a direct consequence of the absence of an on-call 
endoscopy nurse. They concluded that, not only are the most critically ill patients not 
receiving optimal, specialized endoscopy care but endoscope reprocessing under these 
circumstances may be substandard, putting all endoscopy patients (urgent and routine) at 
risk. Also the Australian assessed 'after-hours' endoscopy services at Australian teaching 
hospitals using the British Society of Gastroenterology (BSG) criteria (Gibson, Hitchcock 
et al. 2006). Thirty-four centers (100%) provided complete data. The operation suite 
followed by the endoscopy unit were the most frequently used site. However, one-third of 
centers performed procedures at the bedside, including the emergency department or 
ward. Support staff was not consistently trained endoscopically and, in 15 centers (44%), 
the advanced trainees participated in the 'on call' roster with a consultant present for the 
procedure, although this was not consistently the case. 
 
In contrast to previous surveys, in terms of infrastructure, staff and equipment we 
accomplish all the required criteria for clinical and non-clinical risk management. 
 
If this model improved efficiency by taking a more strategic approach when allocating 
resources to a single unit, remains to be clearly answered. As discussed in paper III, we 
can probably assume potential savings in hospitals where endoscopy is only available 
from Monday to 2pm Friday and in those with difficulties in endoscopy arrangements, 
even on weekdays. Our next step is to know our costs by mapping the patient's journey: 
ED admission; transfer; endoscopy session; costs/bed/day. However, the recent 
guidelines published by the National Institute of Clinical Excellence reported that units with 
more than 330 presentations of AUGIB per year are cost effective with an everyday 
service (2012); they didn't take into account the weekend, with probably more income, 
which is our case. Nevertheless, cost-effectiveness analysis is a method for assessing the 
gains in health relative to the costs of different health interventions. We understand that 
the competitive worldwide economic environment and ever-increasing costs of health care 
have created a setting in which understanding costs and making sure that we achieve 
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Figure 12:  Before and After the Model’s implementation and assessement
good value in health care is crucial. Maybe our intervention model should be compared to 
others in Portugal. But, comparing interventions according to cost-effectiveness criteria 
must be done with a clear understanding that it compares interventions only in terms of 
their efficiency at improving health, and non-health benefits are not introduced into the 
debate, namely patient´s preferences, equity and accessibility. Many other issues may 
limit the value of an intervention and must be considered in decisions, including safety, 
adverse effects as to whether can be practically and widely applied. 
 
Costs and benefits are not always tangible or can be expressed in monetary terms. I 
strongly believe that this emergency model of care offered added value in the 
management of NVAUGIB. 
 
 
 
 
 
 
 
 
 
 
 
 
Ultimately, knowing which interventions work and at what cost has to be tempered by 
knowledge of their performance. Only when scientific and practical knowledge are 
combined can policy makers identify the interventions that will have the most impact in 
practice.  
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Thus the performance analysis presented in this thesis provides an important contribution 
to broader debates about public policy decisions pertaining emergency care in 
gastroenterology. 
 
 
Strengths of our study 
 
 
Research questions 1-3 
Limitations of our study 
 
Research question 4, efficiency 
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VI. CONCLUSIONS 
VIa. Concluding Remarks 
 
Improving the quality of healthcare through the best scientific evidence available in a 
context of scarce resources is a challenge for all the health systems. 
As it was a challenge to think about the quality of emergency care in NVAUGIB and how it 
was organized to provide high quality of care to every patient, every time it is needed. 
Nevertheless I believe we, as clinicians, have an increasingly important role and 
responsibility in the quality of care being offered to patients. But, only quality data can 
enable valid conclusions to be drawn, which in turn enable changes to be made for the 
better. It is therefore necessary to increase the understanding of the causes affecting the 
quality of care, their effects on the quality of such care and how their management can be 
improved.  
 
 There are some longer‐term issues that have been raised in this analysis that are 
worth considering: 
 
1. Out-of-hours endoscopy  is a major  issue, with large and important regional 
variations in process and outcomes, not explained  by differences in patient 
characteristics. 
 
2. Most countries lack a well-coordinated approach to acute bleeding. 
 
3. Barriers to implementation include economic constraints, lack of resources and 
infrastructure. 
 
4. Position statements don´t specifically address after-hours or emergency 
endoscopy. 
 
5. Out-of-hours endoscopy seems to be out of some quality dimensions.  
 
6. Concerning our research in NVAUGIB, a great deal of work has been done and 
significant progress has been made but achieving the goal of a system that is 
capable of working as a whole is not an easy task. In some cases there is a need 
to rethink how the system is managed, to pay  attention to flow through the whole 
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system, the speed at which these different parts work and how they interact to 
create a better flow through, as explained in this thesis. Attention was given to 
what happens to patients before they are referred to URGE, but not to the services 
available to them after discharge or transfer. They are part of a wider system and 
more thought is required about how the system as a whole operates together and 
new measures and data may support this.  
 
7. However, this regionalization model has avoided more fragmentation and 
improved equity and accessibility in a safety and effectiveness manner. 
 
8. It has overcome the problem of emergency provision: the workforce, which must 
be defined and adequate qualitatively and quantitatively. 
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VI. CONCLUSIONS 
VIb. Practical Implications 
 
 
1. The strategy to improve care demonstrated equity, safety, efficiency, timeliness 
and  availability of appropriately trained and experienced endoscopy staff. 
 
2. Scarce health care resources were allocated wisely and fairly. 
 
3. Median time to out-of-hours endoscopy was 6h for direct admissions and 7.7h for 
transferred patients; 90% of the procedures were performed in less than 24h.  
 
4. Age, malignancy and an admission Rockall risk score were predictors of in-
hospital mortality, whatever the admission status. 
 
5. Rates for rebleeding, mortality and need for surgery were similar in transferred vs. 
direct admissions. 
 
 
Resources are limited, and health care must be allocated efficiently, but, equity and 
patient-centeredness are crucial dimensions of quality of care.  
 
The coordinated actions of diverse institutions providers are an essential component; 
clinical guidelines, including safe transfer, must be implemented, disseminated and 
quality continuous monitored. 
 
This may fit in a larger opportunity to improve processes and outcomes in this and 
other clinical contexts. 
 
Nevertheless it is important to determine, in the near future, the impact of 
regionalization in the economics of hospitals within the system. 
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VI. CONCLUSIONS 
VIc. Further Research 
 
 
 In this overview we have shown that regionalized care for NVAUGIB, although 
compelling, is incomplete. 
 
 Recommendations for future areas of research should focus on: 
 
1. Costs of care using cost-effectiveness or cost-utility analysis; 
 
2. Examination of  interhospital variations, particularly within hospitals with 
similar characteristics; 
 
3. Compare the changes to similar areas who did not experience the 
reorganization. 
 
4. Measures of patient satisfaction and preference. 
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